1 | 0.12% saline | - | - | - | - | 1件: 299 299 |
2 | 0.9% Isotonic Saline (IS) | - | - | - | - | 1件: 299 299 |
3 | 0.9% Isotonic Saline (IS), 4mL | - | - | - | - | 1件: 299 299 |
4 | 0.9% normal saline (control) | - | - | - | - | 1件: 299 299 |
5 | 0.9% w/v sodium chloride solution | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
6 | 033841 | - | - | - | - | 1件: 299 299 |
7 | 1,5 (Butylimino)-1,5-dideoxy-D-glucitol | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 299 299 |
8 | 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid | - | - | - | - | 1件: 299 299 |
9 | 100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
10 | 100 mg ELX /50 mg TEZ /75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
11 | 100 mg ELX/50 mg TEZ /75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
12 | 100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination | - | - | - | - | 1件: 299 299 |
13 | 100 mg TEZ/150 mg IVA FDC | - | - | - | - | 1件: 299 299 |
14 | 100 mg VX-445 /50 mg TEZ/75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
15 | 100 mg VX-445/50 mg TEZ /75 mg IVA FDC | - | - | - | - | 1件: 299 299 |
16 | 100 mg/m2 dose | - | - | - | - | 1件: 299 299 |
17 | 100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
18 | 100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
19 | 100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC | - | - | - | - | 1件: 299 299 |
20 | 100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC | - | - | - | - | 1件: 299 299 |
21 | 100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
22 | 100-mg VX-445 /50-mg TEZ/75-mg | - | - | - | - | 1件: 299 299 |
23 | 100-mg VX-445/50-mg TEZ/75-mg IVA FDC | - | - | - | - | 1件: 299 299 |
24 | 100g ELX / 50mg TEZ / 75mg IVA | - | - | - | - | 1件: 299 299 |
25 | 100mg ELX/50mg TEZ /75mg IVA | - | - | - | - | 1件: 299 299 |
26 | 100mg VX-445/50mg TEZ /75mg IVA FDC | - | - | - | - | 1件: 299 299 |
27 | 150-mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
28 | 150mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
29 | 2% Chlorhexidine solution wipes | 1件: Chlorhexidine Chlorhexidine | 1件: D07668
D07668
| - | - | 1件: 299 299 |
30 | 2,3-dihydroxybutanedioic acid | - | - | - | - | 1件: 299 299 |
31 | 2-aminoethanethiol | 1件: Cysteamine Cysteamine | 1件: D03634
D03634
| - | - | 2件: 19 19, 299 |
32 | 200 mg/m2 dose | - | - | - | - | 1件: 299 299 |
33 | 25-Hydroxyvitamin D3 | 1件: Calcifediol Calcifediol | 1件: D00122
D00122
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
34 | 2622U90 Duramycin | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
35 | 291844 | - | - | - | - | 2件: 246 246, 299 |
36 | 4% chlorhexidine gluconate liquid skin cleanser | 1件: Chlorhexidine Chlorhexidine | 1件: D07668
D07668
| - | - | 1件: 299 299 |
37 | 4-phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 2件: 251 251, 299 |
38 | 4.2% NaCl/Inhalation solution | - | - | - | - | 1件: 299 299 |
39 | 4D-710 | - | - | - | - | 1件: 299 299 |
40 | 5-methyltetrahydrofolate and vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 1件: 299 299 |
41 | 50 mg ELX/25 mg TEZ/37.5 mg IVA | - | - | - | - | 1件: 299 299 |
42 | 50 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination | - | - | - | - | 1件: 299 299 |
43 | 5000 IU of cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
44 | 552-02 | - | - | - | - | 2件: 53 53, 299 |
45 | 6% Hypertonic Saline (HS), 4mL | - | - | - | - | 1件: 299 299 |
46 | 7% Hypertonic Saline (HS) | - | - | - | - | 1件: 299 299 |
47 | 7% NaCl | - | - | - | - | 1件: 299 299 |
48 | 7% saline | - | - | - | - | 1件: 299 299 |
49 | 75-mg IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
50 | 80mg ELX / 40mg TEZ / 60mg IVA | - | - | - | - | 1件: 299 299 |
51 | A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP) | - | - | - | - | 1件: 299 299 |
52 | AAC Hexal | - | - | - | - | 1件: 299 299 |
53 | ABBV-119 | - | - | - | - | 1件: 299 299 |
54 | ABBV-2222 | - | - | - | - | 1件: 299 299 |
55 | ABBV-3067 | - | - | - | - | 1件: 299 299 |
56 | ABBV-576 | - | - | - | - | 1件: 299 299 |
57 | ABELCET | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
58 | ACC | - | - | - | - | 1件: 299 299 |
59 | ACC600Tabs | - | - | - | - | 1件: 299 299 |
60 | Acebilustat | 1件: Acebilustat Acebilustat | - | - | - | 1件: 299 299 |
61 | Acetate | 1件: Acetate Acetate | - | - | - | 41件: 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 |
62 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
63 | ACETYLCYSTEINE SODIUM | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
64 | ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable | - | - | - | - | 1件: 299 299 |
65 | Active Treatment Group 7% Hypertonic Saline | - | - | - | - | 1件: 299 299 |
66 | Actrapid 100 IU/ml, Solution for injection in a vial | - | - | - | - | 1件: 299 299 |
67 | Actrapid Penfill 100UI/ml | - | - | - | - | 1件: 299 299 |
68 | Ad26.COV2-S.02 | - | - | - | - | 1件: 299 299 |
69 | Ad5-CB-CFTR | - | - | - | - | 1件: 299 299 |
70 | Adempas | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 86, 88, 225, 299 |
71 | Adempas 0.125 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
72 | Adempas 0.5 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
73 | Adempas 1.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
74 | Adempas 2.0 mg | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 |
75 | Adeno-associated virus-CFTR vector | - | - | - | - | 1件: 299 299 |
76 | Adrenalina | - | - | - | - | 1件: 299 299 |
77 | Adrulipase | - | - | - | - | 1件: 299 299 |
78 | Advagraf prolonged-release hard capsules | 2件: Manganese citrate Manganese citrate, Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
79 | AER002 | - | - | - | - | 1件: 299 299 |
80 | Aeroquin | - | - | - | - | 1件: 299 299 |
81 | Aerosolized, human, plasma-derived Alpha-1 Antitrypsin | - | - | - | - | 1件: 299 299 |
82 | Aerosoltherapy | - | - | - | - | 1件: 299 299 |
83 | AeroVanc | - | - | - | - | 1件: 299 299 |
84 | AIR DNase | - | - | - | - | 1件: 299 299 |
85 | AIR DNase™ | - | - | - | - | 1件: 299 299 |
86 | Ajulemic acid | 1件: Ajulemic acid Ajulemic acid | 1件: D11312
D11312
| 1件: CNR2 CNR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 50 50, 51, 299 |
87 | Alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 4件: 6 6, 13, 298, 299 |
88 | Albuterol | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 12 12, 13, 86, 89, 113, 256, 299 |
89 | Alendronate | 1件: Alendronic acid Alendronic acid | 1件: D07119
D07119
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 7件: 19 19, 41, 46, 50, 271, 274, 299 |
90 | Alendronate sodium | 1件: Alendronic acid Alendronic acid | 1件: D07119
D07119
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 19 19, 299 |
91 | Alginate | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 2件: 53 53, 299 |
92 | Alginate oligosaccharide | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 299 299 |
93 | Allo-hMSCs | - | - | - | - | 2件: 211 211, 299 |
94 | Alpha-1 HC 100 mg | - | - | - | - | 1件: 299 299 |
95 | Alpha-1 HC 200 mg | - | - | - | - | 1件: 299 299 |
96 | Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
97 | Alpha1-Proteinase Inhibitor (Human) | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 |
98 | ALTU-135 | 1件: ALTU-135 ALTU-135 | - | - | - | 1件: 299 299 |
99 | ALTUS-135 | - | - | - | - | 1件: 299 299 |
100 | ALX-009 | - | - | - | - | 1件: 299 299 |
101 | AMIKACIN | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 2件: 60 60, 299 |
102 | Amikacin nebulization | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
103 | AMIKACIN SULFATE | 2件: Amikacin Amikacin, Sulfate ion | 1件: D02543
D02543
| - | - | 1件: 299 299 |
104 | Amikacina | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
105 | Amikacina liposomal (Arikace?) | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
106 | Amikacine | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
107 | Amikacine nebulization | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
108 | Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
109 | Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
110 | AMILASA | - | - | - | - | 1件: 299 299 |
111 | Amiloride | 1件: Amiloride Amiloride | 1件: D07447
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 4件: 13 13, 67, 225, 299 |
112 | Amiloride HCl | 1件: Amiloride Amiloride | 1件: D07447
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
113 | Amiloride Solution for Inhalation | 1件: Amiloride Amiloride | 1件: D07447
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 |
114 | Aminoglycoside | - | - | - | - | 1件: 299 299 |
115 | Amitriptylin | 1件: Amitriptyline Amitriptyline | 1件: D07448
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
116 | Amitriptylin-CT | 1件: Amitriptyline Amitriptyline | 1件: D07448
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
117 | Amitriptylin-ct Tabletten | 1件: Amitriptyline Amitriptyline | 1件: D07448
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 |
118 | Amitriptyline | 1件: Amitriptyline Amitriptyline | 1件: D07448
D07448
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 78 78, 97, 226, 299 |
119 | Amoxicillin | 1件: Amoxicillin Amoxicillin | 2件: D00229
D00229
,
D07452
| - | - | 7件: 6 6, 46, 63, 96, 97, 222, 299 |
120 | Amoxicillin and Clavulanic acid | 1件: Clavulanic acid Clavulanic acid | 1件: D07711
D07711
| - | - | 1件: 299 299 |
121 | Amphotericin | - | - | - | - | 1件: 299 299 |
122 | Amphotericin B | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
123 | AMYLASE | - | - | - | - | 1件: 299 299 |
124 | Anakinra | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 16件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 |
125 | Andecaliximab | - | - | - | - | 4件: 46 46, 96, 97, 299 |
126 | Anti-pseudomonas IgY gargle | - | - | - | - | 1件: 299 299 |
127 | Anti-reflux pharmacotherapy | - | - | - | - | 1件: 299 299 |
128 | Antibiotic | - | - | - | - | 1件: 299 299 |
129 | Antioxidant Cocktail | - | - | - | - | 1件: 299 299 |
130 | Antistaminici H1 - H2 | - | - | - | - | 1件: 299 299 |
131 | AP | - | - | - | - | 4件: 2 2, 6, 13, 299 |
132 | AP-PA02 | - | - | - | - | 1件: 299 299 |
133 | API | - | - | - | - | 2件: 231 231, 299 |
134 | AquADEK | - | - | - | - | 1件: 299 299 |
135 | AquADEKs-2 | - | - | - | - | 1件: 299 299 |
136 | ARCT-032 | - | - | - | - | 1件: 299 299 |
137 | ARD-3150 | - | - | - | - | 1件: 299 299 |
138 | Arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 11件: 46 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299 |
139 | Aridol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
140 | Aridol or Osmohale | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
141 | ARIKACE™ | - | - | - | - | 1件: 299 299 |
142 | Arikayce | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
143 | Arikayce™ | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
144 | Arikayce™ 140 mg | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
145 | Arikayce™ 560 mg | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
146 | Arikayce™ 70 mg | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
147 | ARINA-1 | - | - | - | - | 2件: 228 228, 299 |
148 | ARO-ENaC | - | - | - | - | 1件: 299 299 |
149 | Asthma patients | - | - | - | - | 1件: 299 299 |
150 | ATALUREN | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 6件: 19 19, 113, 140, 246, 299, 329 |
151 | Ataluren (PTC124®) | 1件: Ataluren Ataluren | 1件: D09323
D09323
| - | - | 1件: 299 299 |
152 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 1件: D07474
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 |
153 | Atropina | 1件: Atropine Atropine | 1件: D00113
D00113
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
154 | Augmentin | 1件: Clavulanic acid Clavulanic acid | 1件: D07711
D07711
| - | - | 1件: 299 299 |
155 | Aurexis | - | - | - | - | 1件: 299 299 |
156 | Aurexis® (tefibazumab) | 1件: Tefibazumab Tefibazumab | 1件: D06054
D06054
| - | - | 1件: 299 299 |
157 | Avian polyclonal IgY antibody against PA | - | - | - | - | 1件: 299 299 |
158 | Avibactam | 1件: Avibactam Avibactam | - | - | - | 1件: 299 299 |
159 | AZD1236 | - | - | - | - | 1件: 299 299 |
160 | AZD5634 | - | - | - | - | 1件: 299 299 |
161 | AZD5634 for infusion | - | - | - | - | 1件: 299 299 |
162 | AZD5634 for inhalation | - | - | - | - | 1件: 299 299 |
163 | AZD7986 | - | - | - | - | 2件: 44 44, 299 |
164 | AZD9668 | - | - | - | - | 1件: 299 299 |
165 | Azithromycin | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 |
166 | Azithromycin 250 mg tablets | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
167 | Azithromycin 500 mg film-coated tablet | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
168 | AZITHROMYCIN DIHYDRATE | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 2件: 228 228, 299 |
169 | AZLI | - | - | - | - | 1件: 299 299 |
170 | AZLI 75 mg three times a day (TID) | - | - | - | - | 1件: 299 299 |
171 | AZLI 75 mg three times daily (TID) | - | - | - | - | 1件: 299 299 |
172 | AZLI 75 mg two times a day (BID)/ three times a day (TID) | - | - | - | - | 1件: 299 299 |
173 | AZLI 75 mg two times a day (BID)/three times a day (TID) | - | - | - | - | 1件: 299 299 |
174 | Aztreonam | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 2件: 228 228, 299 |
175 | Aztreonam for Inhalation (AI) | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
176 | Aztreonam for Inhalation Solution | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
177 | Aztreonam for Inhalation Solution (AZLI) | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
178 | AZTREONAM LYSINE | 2件: Aztreonam Aztreonam, Lysine | 2件: D00240
D00240
,
D02304
| - | - | 1件: 299 299 |
179 | Aztreonam Lysine for Inhalation | 2件: Aztreonam Aztreonam, Lysine | 2件: D00240
D00240
,
D02304
| - | - | 1件: 299 299 |
180 | Aztreonam solución para inhalación | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
181 | Aztreonan lysine | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
182 | Bactrim | 1件: Trimethoprim Trimethoprim | 1件: D00145
D00145
| - | - | 1件: 299 299 |
183 | BAY 85-8501 | - | - | - | - | 1件: 299 299 |
184 | BAY q 3939 | - | - | - | - | 1件: 299 299 |
185 | BAY63-2521 | - | - | - | - | 3件: 51 51, 86, 299 |
186 | BAY85-8501 | - | - | - | - | 1件: 299 299 |
187 | BAYQ3939 | - | - | - | - | 1件: 299 299 |
188 | BCG | - | - | - | - | 1件: 299 299 |
189 | BCG TICE Vaccine | - | - | - | - | 1件: 299 299 |
190 | Benralizumab | 1件: Benralizumab Benralizumab | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
191 | Beta-Adrenergic cocktail | - | - | - | - | 1件: 299 299 |
192 | Beta-lactam antibiotic | - | - | - | - | 1件: 299 299 |
193 | Bethkis | - | - | - | - | 1件: 299 299 |
194 | BH4 | - | - | - | - | 5件: 51 51, 86, 124, 240, 299 |
195 | BH4 20mg | - | - | - | - | 1件: 299 299 |
196 | BH4 5mg | - | - | - | - | 1件: 299 299 |
197 | BI 1265162 | - | - | - | - | 1件: 299 299 |
198 | BI 1265162 10 µg | - | - | - | - | 1件: 299 299 |
199 | BI 1265162 100 µg | - | - | - | - | 1件: 299 299 |
200 | BI 1265162 25 µg | - | - | - | - | 1件: 299 299 |
201 | BI 1265162 50 µg | - | - | - | - | 1件: 299 299 |
202 | BI 443651 | - | - | - | - | 1件: 299 299 |
203 | Biaxin ( clarithromycin) | 1件: Clarithromycin Clarithromycin | 1件: D00276
D00276
| - | - | 1件: 299 299 |
204 | BIIL 283 BS (Amelubent) | - | - | - | - | 1件: 299 299 |
205 | BIIL 284 BS, high dose | - | - | - | - | 1件: 299 299 |
206 | BIIL 284 BS, high dose, adult patients | - | - | - | - | 1件: 299 299 |
207 | BIIL 284 BS, high dose, pediatric patients | - | - | - | - | 1件: 299 299 |
208 | BIIL 284 BS, low dose | - | - | - | - | 1件: 299 299 |
209 | BIIL 284 BS, low dose, adult patients | - | - | - | - | 1件: 299 299 |
210 | BIIL 284 BS, low dose, pediatric patients | - | - | - | - | 1件: 299 299 |
211 | BIIL 284 BS, medium dose, adult patients | - | - | - | - | 1件: 299 299 |
212 | BIIL 284 BS, medium dose, pediatric patients | - | - | - | - | 1件: 299 299 |
213 | Biklin | - | - | - | - | 1件: 299 299 |
214 | Bio-25 probiotic | - | - | - | - | 1件: 299 299 |
215 | Bisphosphonate treatment | - | - | - | - | 2件: 113 113, 299 |
216 | BLF | - | - | - | - | 1件: 299 299 |
217 | Blood or Saliva Sample Collection | - | - | - | - | 1件: 299 299 |
218 | Blood sample | - | - | - | - | 20件: 8 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 |
219 | Blood test | - | - | - | - | 6件: 36 36, 51, 107, 113, 162, 299 |
220 | Boost VHC | - | - | - | - | 1件: 299 299 |
221 | Boots High Strength Garlic Odour Controlled | 1件: Garlic Garlic | 1件: D12020
D12020
| - | - | 1件: 299 299 |
222 | BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML | - | - | - | - | 1件: 299 299 |
223 | Bramitob | - | - | - | - | 1件: 299 299 |
224 | BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML | - | - | - | - | 1件: 299 299 |
225 | Bramitob 300mg/4ml Nebuliser Solution | - | - | - | - | 1件: 299 299 |
226 | BRAMITOB*NEBUL 28F 300MG/4ML | - | - | - | - | 1件: 299 299 |
227 | BRAMITOB*NEBUL 56F 300MG/4ML | - | - | - | - | 1件: 299 299 |
228 | Bramitob® administered by PARI eFlow® rapid electronic nebulizer | - | - | - | - | 1件: 299 299 |
229 | Bramitob® administered by PARI LC® PLUS nebulizer | - | - | - | - | 1件: 299 299 |
230 | Brensocatib | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
231 | Brensocatib 10 mg | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
232 | Brensocatib 25 mg | 1件: Brensocatib Brensocatib | 1件: D12120
D12120
| 1件: CTSC CTSC 💬 | 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 |
233 | Broccoli | 1件: Broccoli Broccoli | - | - | - | 3件: 36 36, 97, 299 |
234 | Broccoli sprouts | 1件: Broccoli Broccoli | - | - | - | 1件: 299 299 |
235 | Bronchial mucus collection | - | - | - | - | 1件: 299 299 |
236 | Bronchitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
237 | Bucelipase alfa | 1件: Bucelipase alfa Bucelipase alfa | - | - | - | 1件: 299 299 |
238 | BUDESONIDE | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 |
239 | Budesonide-formoterol single inhaler | 2件: Budesonide Budesonide, Formoterol | 2件: D00246
D00246
,
D07990
| 2件: ADRB2 ADRB2, NR3C1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
240 | Burlulipase | 1件: Burlulipase Burlulipase | - | - | - | 1件: 299 299 |
241 | C01CA04 - Dopamina | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 299 299 |
242 | Calcium | 1件: Calcium Calcium | - | - | - | 27件: 6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 |
243 | Calcium carbonate | 2件: Calcium Calcium, Carbonate ion | - | - | - | 8件: 13 13, 19, 46, 53, 75, 96, 235, 299 |
244 | Calfactant | 1件: Calfactant Calfactant | 1件: D03317
D03317
| - | - | 1件: 299 299 |
245 | Carbonate | 1件: Carbonate ion Carbonate ion | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
246 | Cavosonstat | 1件: Cavosonstat Cavosonstat | 1件: D10916
D10916
| - | - | 1件: 299 299 |
247 | Cayston | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
248 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
249 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
250 | CB-280 | - | - | - | - | 1件: 299 299 |
251 | CEFALEXIN | 1件: Cephalexin Cephalexin | 2件: D00263
D00263
,
D00906
| - | - | 1件: 299 299 |
252 | Cefepime | 1件: Cefepime Cefepime | 1件: D02376
D02376
| - | - | 2件: 60 60, 299 |
253 | Cefiderocol | 1件: Cefiderocol Cefiderocol | 1件: D11302
D11302
| - | - | 1件: 299 299 |
254 | Ceftaroline | 1件: Ceftaroline fosamil Ceftaroline fosamil | 1件: D08884
D08884
| - | - | 1件: 299 299 |
255 | Ceftazidim | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
256 | Ceftazidim Fresenius Kabi | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
257 | Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
258 | Ceftazidima | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
259 | CEFTAZIDIMA PENTAIDRATO | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
260 | CEFTAZIDIME | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
261 | Ceftazidime and tobramycin | 2件: Ceftazidime Ceftazidime, Tobramycin | 3件: D00063
D00063
,
D00921
,
D07654
| - | - | 1件: 299 299 |
262 | CEFTAZIDIME PENTAHYDRATE | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
263 | Ceftazidime/avibactam | 2件: Avibactam Avibactam, Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
264 | Ceftolozane | 1件: Ceftolozane Ceftolozane | 1件: D10097
D10097
| - | - | 1件: 299 299 |
265 | Ceftolozane/Tazobactam | 2件: Ceftolozane Ceftolozane, Tazobactam | 2件: D00660
D00660
,
D10097
| - | - | 1件: 299 299 |
266 | Cefuroxim | 1件: Cefuroxime Cefuroxime | 1件: D00262
D00262
| - | - | 1件: 299 299 |
267 | Cefuroxime | 1件: Cefuroxime Cefuroxime | 1件: D00262
D00262
| - | - | 2件: 97 97, 299 |
268 | Cephalexin | 1件: Cephalexin Cephalexin | 2件: D00263
D00263
,
D00906
| - | - | 1件: 299 299 |
269 | CF patients with a G551D mutation and treated with Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
270 | CFTR Modulators | - | - | - | - | 1件: 299 299 |
271 | CFTR potentiator | - | - | - | - | 1件: 299 299 |
272 | ChAdOx1 nCoV-19 | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 299 |
273 | CHF 6333 | - | - | - | - | 1件: 299 299 |
274 | CHF6333 (Part 1 - SAD) | - | - | - | - | 1件: 299 299 |
275 | CHF6333 (Part 2 - MAD) | - | - | - | - | 1件: 299 299 |
276 | Chlorhexidine | 1件: Chlorhexidine Chlorhexidine | 1件: D07668
D07668
| - | - | 2件: 86 86, 299 |
277 | Chlorhexidine Gluconate | 1件: Chlorhexidine Chlorhexidine | 1件: D07668
D07668
| - | - | 1件: 299 299 |
278 | Chlorhexidine gluconate oral rinse | 1件: Chlorhexidine Chlorhexidine | 1件: D07668
D07668
| - | - | 1件: 299 299 |
279 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 |
280 | CHOLECALCIFEROL | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 |
281 | Cholecalciferol (Vitamin D3) | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 13 13, 299 |
282 | Cholecalciferol (vitaminD3) | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
283 | Cholecalciferol Pill | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
284 | Choline | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 4件: 93 93, 171, 193, 299 |
285 | Choline Chloride | 2件: Chloride ion Chloride ion, Choline | 1件: D07690
D07690
| - | - | 1件: 299 299 |
286 | Choline supplementation | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 1件: 299 299 |
287 | CILASTATIN | 1件: Cilastatin Cilastatin | 1件: D07698
D07698
| 1件: DPEP1 DPEP1 💬 | - | 2件: 60 60, 299 |
288 | Cipro (Ciprofloxacin, BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
289 | Cipro Inhale | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
290 | Ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 5件: 2 2, 60, 96, 97, 299 |
291 | Ciprofloxacin (BAYQ3939) dry powder for inhalation | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
292 | Ciprofloxacin (Cipro Inhale, BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
293 | Ciprofloxacin (Cipro, BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
294 | Ciprofloxacin (ciproxin) | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
295 | Ciprofloxacin dispersion for inhalation | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
296 | Ciprofloxacin DPI | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
297 | Ciprofloxacin DPI (BAYQ3939) | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
298 | Ciprofloxacin for Inhalation | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
299 | Ciprofloxacin hydrochloride | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 2件: 96 96, 299 |
300 | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
301 | Ciprofloxacin Inhale | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
302 | Ciprofloxacina | - | - | - | - | 1件: 299 299 |
303 | CIPROFLOXACINA CLORIDRATO | - | - | - | - | 1件: 299 299 |
304 | Ciproxin | - | - | - | - | 1件: 299 299 |
305 | CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE | - | - | - | - | 1件: 299 299 |
306 | Ciproxin Suspension | - | - | - | - | 1件: 299 299 |
307 | CIPROXIN*6CPR RIV 500MG | - | - | - | - | 1件: 299 299 |
308 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: D00276
D00276
| - | - | 8件: 6 6, 63, 84, 96, 97, 222, 228, 299 |
309 | Claritromycin | - | - | - | - | 1件: 299 299 |
310 | Claritromycin 500mg film coated tablets | - | - | - | - | 1件: 299 299 |
311 | Clavulanate | 1件: Clavulanic acid Clavulanic acid | 1件: D07711
D07711
| - | - | 1件: 299 299 |
312 | CLAVULANIC ACID | 1件: Clavulanic acid Clavulanic acid | 1件: D07711
D07711
| - | - | 1件: 299 299 |
313 | Clindamycin | 1件: Clindamycin Clindamycin | 1件: D00277
D00277
| - | - | 2件: 46 46, 299 |
314 | CLORURO SODICO 7% | - | - | - | - | 1件: 299 299 |
315 | Cobamamide | 1件: Cobamamide Cobamamide | 1件: D00042
D00042
| - | - | 1件: 299 299 |
316 | Colfinair 2 MIU Powder for Nebuliser Solution | - | - | - | - | 1件: 299 299 |
317 | Colimicina | - | - | - | - | 1件: 299 299 |
318 | COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML | - | - | - | - | 1件: 299 299 |
319 | Colimycine | - | - | - | - | 1件: 299 299 |
320 | COLIMYCINE inhalation | - | - | - | - | 1件: 299 299 |
321 | COLIMYCINE injectable | - | - | - | - | 1件: 299 299 |
322 | COLISTIMETATO SODICO | - | - | - | - | 1件: 299 299 |
323 | Colistimethat-Natrium | - | - | - | - | 1件: 299 299 |
324 | COLISTIMETHATE | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
325 | Colistimethate 75 mg inhaled two times daily | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
326 | COLISTIMETHATE SODIUM | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
327 | COLISTIMETHATE SODIUM (A COMPONENT) | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
328 | Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate | 2件: Colistimethate Colistimethate, Colistin | 1件: D07746
D07746
| - | - | 1件: 299 299 |
329 | Colistimethate sodium (CMS) | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
330 | Colistimethate sodium (promixin) | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
331 | COLISTIN | 1件: Colistin Colistin | 1件: D07746
D07746
| - | - | 1件: 299 299 |
332 | Colistin CF | 1件: Colistin Colistin | 1件: D07746
D07746
| - | - | 1件: 299 299 |
333 | Colistin Forest - Trockenstechampullen mit Lösungsmittel | 1件: Colistin Colistin | 1件: D07746
D07746
| - | - | 1件: 299 299 |
334 | COLISTIN MESILATE SODIUM | 1件: Colistin Colistin | 1件: D07746
D07746
| - | - | 1件: 299 299 |
335 | Colistineb | - | - | - | - | 1件: 299 299 |
336 | COLISTINEB 2MUI | - | - | - | - | 1件: 299 299 |
337 | Colobreathe | 1件: Colistimethate Colistimethate | - | - | - | 1件: 299 299 |
338 | Colomycin | - | - | - | - | 1件: 299 299 |
339 | Comirnaty | 1件: Tozinameran Tozinameran | 1件: D11971
D11971
| - | - | 5件: 13 13, 46, 51, 53, 299 |
340 | Comirnaty concentrate for dispersion for injection | 1件: Tozinameran Tozinameran | 1件: D11971
D11971
| - | - | 2件: 53 53, 299 |
341 | Compound 1a | - | - | - | - | 2件: 246 246, 299 |
342 | Continuous infusion Cefepime | 1件: Cefepime Cefepime | 1件: D02376
D02376
| - | - | 1件: 299 299 |
343 | Continuous infusion Ceftazidime | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
344 | Continuous infusion Meropenem | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
345 | Continuous infusion Piperacillin tazobactam | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
346 | Continuous infusion Ticarcillin-clavulanate | 2件: Clavulanic acid Clavulanic acid, Ticarcillin | 2件: D07711
D07711
,
D08593
| - | - | 1件: 299 299 |
347 | Control | - | - | - | - | 4件: 6 6, 46, 168, 299 |
348 | Control Group 0.9% Isotonic Saline | - | - | - | - | 1件: 299 299 |
349 | Control multivitamin | - | - | - | - | 1件: 299 299 |
350 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | 4件: 13 13, 46, 51, 299 |
351 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | 4件: 13 13, 46, 51, 299 |
352 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | 1件: 299 299 |
353 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | 3件: 46 46, 51, 299 |
354 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 299 |
355 | Covid-19 Vaccine Janssen | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: D12129
D12129
| - | - | 2件: 53 53, 299 |
356 | COVID-19 Vaccine Janssen suspension for injection | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: D12129
D12129
| - | - | 1件: 299 299 |
357 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | 1件: Janssen COVID-19 Vaccine Janssen COVID-19 Vaccine | 1件: D12129
D12129
| - | - | 2件: 53 53, 299 |
358 | COVID-19 Vaccine Moderna | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 4件: 46 46, 51, 65, 299 |
359 | COVID-19 Vaccine Moderna dispersion for injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
360 | CPX | - | - | - | - | 1件: 299 299 |
361 | CR002 | 1件: CR002 CR002 | - | - | - | 1件: 299 299 |
362 | CR002 Liquid API | 1件: CR002 CR002 | - | - | - | 1件: 299 299 |
363 | CRC3357, ZK-355322, Leukoton | - | - | - | - | 1件: 299 299 |
364 | CREON | - | - | - | - | 2件: 298 298, 299 |
365 | Creon 10.000, hårde enterokapsler | - | - | - | - | 1件: 299 299 |
366 | Creon 10000 | - | - | - | - | 2件: 298 298, 299 |
367 | CREON 10000 Capsules | - | - | - | - | 1件: 299 299 |
368 | Creon 25.000, hårde enterokapsler | - | - | - | - | 1件: 299 299 |
369 | Creon 25000 | - | - | - | - | 2件: 298 298, 299 |
370 | Creon 40.000, hårde enterokapsler | - | - | - | - | 1件: 299 299 |
371 | CREON IR | - | - | - | - | 1件: 299 299 |
372 | Creon N | - | - | - | - | 1件: 299 299 |
373 | CREON N 25000 | - | - | - | - | 1件: 299 299 |
374 | Creon® | - | - | - | - | 1件: 299 299 |
375 | Creon® (DR/GR) | - | - | - | - | 1件: 299 299 |
376 | Creon® 25,000 | - | - | - | - | 1件: 299 299 |
377 | Crestor | 1件: Rosuvastatin Rosuvastatin | 1件: D08492
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 49 49, 79, 299 |
378 | CSL787 | - | - | - | - | 1件: 299 299 |
379 | CTX-4430 | - | - | - | - | 1件: 299 299 |
380 | Curcuma Longa | 1件: Turmeric Turmeric | - | - | - | 2件: 96 96, 299 |
381 | Curcuma Longa Extract | 1件: Turmeric Turmeric | - | - | - | 1件: 299 299 |
382 | Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg | 1件: Turmeric Turmeric | - | - | - | 1件: 299 299 |
383 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 10件: 2 2, 13, 46, 67, 74, 94, 96, 97, 139, 299 |
384 | CYC202 | - | - | - | - | 1件: 299 299 |
385 | CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL] | - | - | - | - | 1件: 299 299 |
386 | CYSTAGON | 1件: Cysteamine Cysteamine | 1件: D03634
D03634
| - | - | 3件: 8 8, 19, 299 |
387 | Cystagon (cysteamine bitartrate) immediate-release capsules | 1件: Cysteamine Cysteamine | 1件: D03634
D03634
| - | - | 1件: 299 299 |
388 | Cysteamine | 1件: Cysteamine Cysteamine | 1件: D03634
D03634
| - | - | 4件: 8 8, 19, 21, 299 |
389 | Cysteamine Bitartrate | 1件: Cysteamine Cysteamine | 1件: D03634
D03634
| - | - | 4件: 8 8, 19, 21, 299 |
390 | Cysteamine bitartrate (Cystagon) | 1件: Cysteamine Cysteamine | 1件: D03634
D03634
| - | - | 1件: 299 299 |
391 | Cystic Fibrosis Ready to Use Supplemental Food | - | - | - | - | 1件: 299 299 |
392 | Cystic fibrosis transmembrane conductance regulator | - | - | - | - | 1件: 299 299 |
393 | D-a-tocopheryl PEG 1000 succinate | - | - | - | - | 1件: 299 299 |
394 | D-glucitol | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 2件: 28 28, 299 |
395 | D-IVA | - | - | - | - | 1件: 299 299 |
396 | D6-25-hydroxyvitamin D3 | 1件: Calcifediol Calcifediol | 1件: D00122
D00122
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
397 | DCI | - | - | - | - | 2件: 6 6, 299 |
398 | DCI 1020 | - | - | - | - | 1件: 299 299 |
399 | Decolonization | - | - | - | - | 1件: 299 299 |
400 | Denosumab | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 8件: 46 46, 50, 70, 93, 95, 96, 274, 299 |
401 | Denufosol | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
402 | Denufosol tetrasodium (INS37217) | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
403 | Denufosol Tetrasodium (INS37217) Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
404 | Denufosol tetrasodium Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
405 | DEPELESTAT | - | - | - | - | 1件: 299 299 |
406 | Desoxyribonuclease | 1件: Desoxyribonuclease Desoxyribonuclease | - | - | - | 1件: 299 299 |
407 | Detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
408 | Detoxifying agents for antineoplastic treatment | - | - | - | - | 2件: 299 299, 337 |
409 | Deuterated Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
410 | DEUTIVACAFTOR | 1件: Deutivacaftor Deutivacaftor | 1件: D11423
D11423
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
411 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
412 | Dexamethasone sodium phosphate 250 mg/10 ml solution | 2件: Dexamethasone Dexamethasone, Phosphate ion | 1件: D00292
D00292
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
413 | DHA | - | - | - | - | 8件: 6 6, 46, 48, 49, 94, 113, 299, 301 |
414 | DICLOXACILLIN | 1件: Dicloxacillin Dicloxacillin | 1件: D02348
D02348
| - | - | 1件: 299 299 |
415 | Diet | - | - | - | - | 4件: 86 86, 97, 240, 299 |
416 | Digitoxin | 1件: Digitoxin Digitoxin | 1件: D00297
D00297
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
417 | Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics) | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
418 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 7件: 6 6, 49, 90, 94, 240, 299, 301 |
419 | Docosahexaenoic Acid (DHA) | 1件: Doconexent Doconexent | - | - | - | 3件: 6 6, 94, 299 |
420 | Docosahexaenoic acid administration: 50 mg/kg/day during 12 months | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
421 | Docosahexanoic Acid | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
422 | Docosahexanoic Acid Supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
423 | Dopamina | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 299 299 |
424 | DORIBAX | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
425 | Doripenem | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
426 | DORIPENEM HYDRATE | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
427 | Dornase alfa | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 2件: 53 53, 299 |
428 | Dornase alfa (Pulmozyme) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
429 | Dornase alfa [Pulmozyme®] | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
430 | Dornase alpha | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
431 | Doxycyclin | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 2件: 97 97, 299 |
432 | Doxycycline | 1件: Doxycycline Doxycycline | 2件: D00307
D00307
,
D07876
| - | - | 17件: 13 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
433 | DP Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
434 | Dry powder tobramycin | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
435 | DTPA | 1件: Pentetic acid Pentetic acid | 1件: D05422
D05422
| - | - | 2件: 28 28, 299 |
436 | Dulaglutide | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
437 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
438 | DURAMYCIN | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
439 | Duramycin, 2622U90 | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
440 | DX-890 | - | - | - | - | 1件: 299 299 |
441 | Ebselen | 1件: Ebselen Ebselen | - | - | - | 1件: 299 299 |
442 | ECGC | - | - | - | - | 1件: 299 299 |
443 | EGCG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 9件: 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
444 | EGCG + Tocotrienol | 2件: Epigallocatechin gallate Epigallocatechin gallate, Tocotrienol | - | - | - | 1件: 299 299 |
445 | Elasomeran | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 299 299 |
446 | ELEXACAFTOR | 1件: Elexacaftor Elexacaftor | 1件: D11507
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
447 | Elexacaftor / Ivacaftor / Tezacaftor | 3件: Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | 3件: D09916
D09916
,
D11041
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
448 | Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening | 3件: Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | 3件: D09916
D09916
,
D11041
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
449 | Elexacaftor-tezacaftor-ivacaftor exposure | 3件: Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | 3件: D09916
D09916
,
D11041
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
450 | Elexacaftor/tezacaftor/ivacaftor | 3件: Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | 3件: D09916
D09916
,
D11041
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
451 | ELX | - | - | - | - | 1件: 299 299 |
452 | ELX (VX-445)/TEZ (VX-661)/IVA (VX-770) | - | - | - | - | 1件: 299 299 |
453 | ELX-02 | 1件: ELX-02 ELX-02 | - | - | - | 3件: 19 19, 218, 299 |
454 | ELX/TEZ/IVA | - | - | - | - | 1件: 299 299 |
455 | EMEA/H/C/000125 | - | - | - | - | 1件: 299 299 |
456 | End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care | - | - | - | - | 2件: 113 113, 299 |
457 | Engineerd Protein Inhibitor of human Neutrophil Elastase | - | - | - | - | 1件: 299 299 |
458 | Engineered Protein Inhibitor of human Neutrophil Elastase | - | - | - | - | 1件: 299 299 |
459 | Ensure High Protein | - | - | - | - | 1件: 299 299 |
460 | Ensure plus | - | - | - | - | 1件: 299 299 |
461 | EPI-hNE4 DX-890 | - | - | - | - | 1件: 299 299 |
462 | Ergocalciferol | 1件: Ergocalciferol Ergocalciferol | 1件: D00187
D00187
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 46 46, 84, 96, 97, 299 |
463 | Ergocalciferol (vitamin D2) | 1件: Ergocalciferol Ergocalciferol | 1件: D00187
D00187
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
464 | Esomeprazole | 1件: Esomeprazole Esomeprazole | 1件: D07917
D07917
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 8件: 13 13, 46, 86, 98, 107, 113, 298, 299 |
465 | Essential amino acid intake + Leucine vs total AA supplement | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 1件: 299 299 |
466 | Estradiol | 1件: Estradiol Estradiol | 1件: D00105
D00105
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 7件: 13 13, 46, 49, 65, 76, 226, 299 |
467 | Estradiol 2 mg | 1件: Estradiol Estradiol | 1件: D00105
D00105
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 |
468 | ETD001 multiple once daily doses | - | - | - | - | 1件: 299 299 |
469 | ETD001 multiple twice daily doses | - | - | - | - | 1件: 299 299 |
470 | ETD001 single dose | - | - | - | - | 1件: 299 299 |
471 | Ethambutol | 1件: Ethambutol Ethambutol | 1件: D07925
D07925
| - | - | 2件: 84 84, 299 |
472 | Ethinyl estradiol | 2件: Estradiol Estradiol, Ethinylestradiol | 2件: D00105
D00105
,
D00554
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 3件: 46 46, 49, 299 |
473 | EU Orphan Designation Number EU/3/02/120 | - | - | - | - | 1件: 299 299 |
474 | EUR-1008 | - | - | - | - | 1件: 299 299 |
475 | EUR-1008 (APT-1008) | - | - | - | - | 1件: 299 299 |
476 | EUR-1008 25,000 Units | - | - | - | - | 1件: 299 299 |
477 | Ex-vivo approach concerning 25 patients | - | - | - | - | 2件: 102 102, 299 |
478 | Exercise | - | - | - | - | 1件: 299 299 |
479 | EZ-2053 | - | - | - | - | 2件: 85 85, 299 |
480 | EZ-2053 5mg/kg | - | - | - | - | 2件: 85 85, 299 |
481 | F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid) | - | - | - | - | 1件: 299 299 |
482 | Fasenra | 1件: Benralizumab Benralizumab | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
483 | FDL169 | 1件: FDL169 FDL169 | - | - | - | 1件: 299 299 |
484 | FDL176 | - | - | - | - | 1件: 299 299 |
485 | FDL176 & FDL169 coadministration | 1件: FDL169 FDL169 | - | - | - | 1件: 299 299 |
486 | Fenretinide | 1件: Fenretinide Fenretinide | 1件: D04162
D04162
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 299 299 |
487 | Ferinject | - | - | - | - | 2件: 86 86, 299 |
488 | FERRIC CARBOXYMALTOSE | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: D08920
D08920
| - | - | 4件: 86 86, 96, 97, 299 |
489 | Ferrous sulfate 325mg | 1件: Sulfate ion Sulfate ion | - | - | - | 1件: 299 299 |
490 | Finely ground flaxseed powder | 1件: Flax seed Flax seed | - | - | - | 1件: 299 299 |
491 | Fish Oil | 1件: Fish oil Fish oil | - | - | - | 8件: 13 13, 46, 49, 66, 96, 260, 294, 299 |
492 | Flaxseed | 1件: Flax seed Flax seed | - | - | - | 2件: 97 97, 299 |
493 | FLUCLOXACILLIN | 1件: Flucloxacillin Flucloxacillin | 1件: D04196
D04196
| - | - | 1件: 299 299 |
494 | Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution | 1件: Flucloxacillin Flucloxacillin | 1件: D04196
D04196
| - | - | 1件: 299 299 |
495 | FLUCLOXACILLIN SODIUM | 1件: Flucloxacillin Flucloxacillin | 1件: D04196
D04196
| - | - | 1件: 299 299 |
496 | Flucloxicillin | - | - | - | - | 1件: 299 299 |
497 | FluMist | 1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen | - | - | - | 1件: 299 299 |
498 | Flumist® | 1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen | - | - | - | 1件: 299 299 |
499 | Fluticasone | 1件: Fluticasone Fluticasone | 1件: D07981
D07981
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 |
500 | FORLAX 4 g, poudre pour solution buvable en sachet | - | - | - | - | 1件: 299 299 |
501 | Formoterol | 1件: Formoterol Formoterol | 1件: D07990
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
502 | Fortum | - | - | - | - | 1件: 299 299 |
503 | FTI, AZLI | - | - | - | - | 1件: 299 299 |
504 | Fucidin | 1件: Fusidic acid Fusidic acid | 1件: D04281
D04281
| - | - | 1件: 299 299 |
505 | Fucidin Tablets | 1件: Fusidic acid Fusidic acid | 1件: D04281
D04281
| - | - | 1件: 299 299 |
506 | Fusidate | 1件: Fusidic acid Fusidic acid | 1件: D04281
D04281
| - | - | 1件: 299 299 |
507 | FUSIDIC ACID | 1件: Fusidic acid Fusidic acid | 1件: D04281
D04281
| - | - | 1件: 299 299 |
508 | Fusidin | - | - | - | - | 1件: 299 299 |
509 | G1117337 | - | - | - | - | 2件: 67 67, 299 |
510 | G914167 | - | - | - | - | 1件: 299 299 |
511 | G957389 | - | - | - | - | 1件: 299 299 |
512 | GALICAFTOR | 1件: Galicaftor Galicaftor | 1件: D11724
D11724
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
513 | Gallium nitrate | 2件: Gallium nitrate Gallium nitrate, Nitrate | 2件: D00940
D00940
,
D02313
| - | - | 1件: 299 299 |
514 | Garlic | 1件: Garlic Garlic | 1件: D12020
D12020
| - | - | 1件: 299 299 |
515 | Genetic testing | - | - | - | - | 3件: 6 6, 90, 299 |
516 | GENISTEIN | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 2件: 19 19, 299 |
517 | Genistein (Unconjugated Isoflavones 100) | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 1件: 299 299 |
518 | Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg | - | - | - | - | 1件: 299 299 |
519 | Gentamicin | 1件: Gentamicin Gentamicin | 1件: D08013
D08013
| - | - | 3件: 36 36, 113, 299 |
520 | Gernebcin | - | - | - | - | 1件: 299 299 |
521 | Gernebcin 80 mg | - | - | - | - | 1件: 299 299 |
522 | Ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 |
523 | GIP | - | - | - | - | 1件: 299 299 |
524 | Giving DHA-rich supplement | - | - | - | - | 1件: 299 299 |
525 | Glargine | - | - | - | - | 1件: 299 299 |
526 | Glargine insulin | - | - | - | - | 1件: 299 299 |
527 | GLP-1 | - | - | - | - | 1件: 299 299 |
528 | GLPG1837 | - | - | - | - | 1件: 299 299 |
529 | GLPG1837 dose 1 | - | - | - | - | 1件: 299 299 |
530 | GLPG1837 dose 2 | - | - | - | - | 1件: 299 299 |
531 | GLPG1837 dose 3 | - | - | - | - | 1件: 299 299 |
532 | GLPG2222 | - | - | - | - | 1件: 299 299 |
533 | GLPG2222 100 mg | - | - | - | - | 1件: 299 299 |
534 | GLPG2222 150 mg q.d. | - | - | - | - | 1件: 299 299 |
535 | GLPG2222 200 mg | - | - | - | - | 1件: 299 299 |
536 | GLPG2222 300 mg q.d. | - | - | - | - | 1件: 299 299 |
537 | GLPG2222 400 mg | - | - | - | - | 1件: 299 299 |
538 | GLPG2222 50 mg | - | - | - | - | 1件: 299 299 |
539 | GLPG2451 dose regimen A | - | - | - | - | 1件: 299 299 |
540 | GLPG2451 dose regimen B | - | - | - | - | 1件: 299 299 |
541 | GLPG2737 | - | - | - | - | 2件: 67 67, 299 |
542 | GLPG2737 single dose | - | - | - | - | 1件: 299 299 |
543 | GLPG3067 | - | - | - | - | 1件: 299 299 |
544 | GLPG3067 single dose | - | - | - | - | 1件: 299 299 |
545 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 12件: 2 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 |
546 | Glutamine | 1件: L-Glutamine L-Glutamine | 1件: D00015
D00015
| - | - | 8件: 87 87, 89, 96, 97, 113, 222, 245, 299 |
547 | Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
548 | GLUTATHIONE SODIUM | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
549 | GLYCINE | 1件: Glycine Glycine | 1件: D00011
D00011
| - | - | 5件: 35 35, 60, 86, 226, 299 |
550 | Glycine Buffer | 1件: Glycine Glycine | 1件: D00011
D00011
| - | - | 1件: 299 299 |
551 | GlycosBio Nutritional Supplement | - | - | - | - | 1件: 299 299 |
552 | GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.) | - | - | - | - | 1件: 299 299 |
553 | Growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 14件: 2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 |
554 | GS-5737 | - | - | - | - | 1件: 299 299 |
555 | GS-5745 | 1件: GS-5745 GS-5745 | - | - | - | 4件: 46 46, 96, 97, 299 |
556 | GS-9411 | - | - | - | - | 1件: 299 299 |
557 | GSH | - | - | - | - | 2件: 6 6, 299 |
558 | GSH (Glutathione) | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
559 | H02 - Corticosteroidi Sistemici | - | - | - | - | 1件: 299 299 |
560 | H5.001CBCFTR | - | - | - | - | 1件: 299 299 |
561 | Helium | 1件: Helium Helium | 1件: D04420
D04420
| - | - | 3件: 228 228, 299, 330 |
562 | Helium-3 | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 2件: 228 228, 299 |
563 | Heparin | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 11件: 47 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 |
564 | Heparin 25mg inhalation powder, hard capsule | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 299 299 |
565 | Heparin Sodium | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 280 280, 299 |
566 | Heracillin | - | - | - | - | 1件: 299 299 |
567 | High dose of budesonide | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
568 | High-Dose Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
569 | HMSCs | - | - | - | - | 1件: 299 299 |
570 | HP 129Xe | - | - | - | - | 1件: 299 299 |
571 | HP 3He | - | - | - | - | 1件: 299 299 |
572 | HSK31858 | - | - | - | - | 1件: 299 299 |
573 | Human recombinant growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 2件: 13 13, 299 |
574 | Hydrocortisone | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
575 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 1件: D08050
D08050
| - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
576 | Hyperglycemic clamp | - | - | - | - | 1件: 299 299 |
577 | Hyperglycemic Clamp with concurrent GIP infusion | - | - | - | - | 1件: 299 299 |
578 | Hyperglycemic clamp with concurrent GLP-1 infusion | - | - | - | - | 1件: 299 299 |
579 | Hyperpolarized Helium-3 | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 299 299 |
580 | Hyperpolarized Helium-3 MRI of the chest | 2件: Helium Helium, Helium He-3 | 1件: D04420
D04420
| - | - | 1件: 299 299 |
581 | Hyperpolarized Xe129 | - | - | - | - | 4件: 51 51, 85, 86, 299 |
582 | Hyperpolarized Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
583 | Hyperpolarized Xenon 129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
584 | Hyperpolarized Xenon gas | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
585 | Hyperpolarized xenon-129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
586 | Hypertonic bicarbonate | - | - | - | - | 1件: 299 299 |
587 | HYPERTONIC SALINE | - | - | - | - | 1件: 299 299 |
588 | Hypertonic saline (7 %) and isotonic saline (0.9%) | - | - | - | - | 1件: 299 299 |
589 | Hypertonic saline (7%) | - | - | - | - | 1件: 299 299 |
590 | Hypertonic saline 6% - | - | - | - | - | 1件: 299 299 |
591 | Hypertonic Saline 7% | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
592 | Hypertonic saline solution | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
593 | Ibuprofen | 1件: Ibuprofen Ibuprofen | 1件: D00126
D00126
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 7件: 13 13, 46, 65, 107, 113, 271, 299 |
594 | Icenticaftor | - | - | - | - | 1件: 299 299 |
595 | ICS+LABA | - | - | - | - | 1件: 299 299 |
596 | IDPM | - | - | - | - | 1件: 299 299 |
597 | IDPM: Inhaled Dry Powder Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
598 | IGE025 | - | - | - | - | 1件: 299 299 |
599 | IgY | - | - | - | - | 1件: 299 299 |
600 | IMIPENEM | 1件: Imipenem Imipenem | 2件: D00206
D00206
,
D04515
| - | - | 2件: 60 60, 299 |
601 | Imipenem/Cilastatin/Relebactam | 3件: Cilastatin Cilastatin, Imipenem, Relebactam | 4件: D00206
D00206
,
D04515
,
D07698
,
D10726
| 1件: DPEP1 DPEP1 💬 | - | 1件: 299 299 |
602 | Impact | - | - | - | - | 5件: 46 46, 50, 53, 85, 299 |
603 | Impact-Nutridrink | - | - | - | - | 1件: 299 299 |
604 | In-vitro approach concerning 25 patients | - | - | - | - | 2件: 102 102, 299 |
605 | Increlex | 1件: Mecasermin Mecasermin | 1件: D03297
D03297
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 4件: 65 65, 78, 96, 299 |
606 | INCRELEX*SC 1FL 4ML 10MG/ML | 1件: Mecasermin Mecasermin | 1件: D03297
D03297
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 299 299 |
607 | Indium | 1件: Indium Indium | - | - | - | 3件: 28 28, 84, 299 |
608 | Indium-DTPA | 2件: Indium Indium, Pentetic acid | 1件: D05422
D05422
| - | - | 1件: 299 299 |
609 | INDUSIL*OS GTT FL 30MG+FL 15ML | - | - | - | - | 1件: 299 299 |
610 | Influenza vaccination | - | - | - | - | 1件: 299 299 |
611 | Inhaled 7% hypertonic saline (HS) | - | - | - | - | 1件: 299 299 |
612 | Inhaled AR-501 | - | - | - | - | 1件: 299 299 |
613 | Inhaled Dry Powder Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
614 | Inhaled hypertonic saline (7%) | - | - | - | - | 1件: 299 299 |
615 | Inhaled Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
616 | Inhaled Reduced Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
617 | Inhaled SNSP113 | - | - | - | - | 1件: 299 299 |
618 | Inhaled Sodium Pyruvate | - | - | - | - | 1件: 299 299 |
619 | Inhaled tobramycin | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
620 | Inhaled Vancomycin | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 1件: 299 299 |
621 | Initiation of CFTR Modulator | - | - | - | - | 1件: 299 299 |
622 | INOmax | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 3件: 85 85, 294, 299 |
623 | INOmax 400ppm mol/mol inhalation gas | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 2件: 85 85, 299 |
624 | INS1007 | - | - | - | - | 2件: 44 44, 299 |
625 | INS1007 10 mg oral tablet | - | - | - | - | 1件: 299 299 |
626 | INS1007 25 mg oral tablet | - | - | - | - | 1件: 299 299 |
627 | Insulin | - | - | - | - | 6件: 6 6, 13, 46, 75, 78, 299 |
628 | Insulin Asparte | - | - | - | - | 1件: 299 299 |
629 | Insulin detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
630 | Insulin detemir [rDNA origin] injection | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
631 | Insulin glargine | 1件: Insulin glargine Insulin glargine | 1件: D03250
D03250
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
632 | Insuline humaine recombinante | - | - | - | - | 1件: 299 299 |
633 | Interferon Gamma | 1件: Interferon Gamma Interferon Gamma | - | - | - | 8件: 18 18, 65, 85, 107, 228, 299, 301, 326 |
634 | INTERFERON GAMMA-1B | 2件: Interferon Gamma Interferon Gamma, Interferon gamma-1b | 1件: D00747
D00747
| 2件: IFNGR1 IFNGR1, IFNGR2 💬 | 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 |
635 | Intermittent, short infusion Cefepime | 1件: Cefepime Cefepime | 1件: D02376
D02376
| - | - | 1件: 299 299 |
636 | Intermittent, short infusion Ceftazidime | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
637 | Intermittent, short infusion Meropenem | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
638 | Intermittent, short infusion Piperacillin tazobactam | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
639 | Intermittent, short infusion Ticarcillin-clavulanate | 2件: Clavulanic acid Clavulanic acid, Ticarcillin | 2件: D07711
D07711
,
D08593
| - | - | 1件: 299 299 |
640 | Inulin | 1件: Inulin Inulin | 1件: D00171
D00171
| - | - | 4件: 6 6, 96, 156, 299 |
641 | IONIS-ENaCRx | - | - | - | - | 1件: 299 299 |
642 | ISOTONIC SALINE | - | - | - | - | 1件: 299 299 |
643 | Isotonic saline 0.9% | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
644 | Itraconazole | 1件: Itraconazole Itraconazole | 1件: D00350
D00350
| - | - | 6件: 3 3, 46, 65, 96, 227, 299 |
645 | Itraconazole/voriconazole | 2件: Itraconazole Itraconazole, Voriconazole | 2件: D00350
D00350
,
D00578
| - | - | 1件: 299 299 |
646 | IV amikacin | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
647 | IV ceftazidime | 1件: Ceftazidime Ceftazidime | 2件: D00921
D00921
,
D07654
| - | - | 1件: 299 299 |
648 | IV meropenem | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
649 | IV piperacillin-tazobactam | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
650 | IV ticarcillin-clavulanate | 2件: Clavulanic acid Clavulanic acid, Ticarcillin | 2件: D07711
D07711
,
D08593
| - | - | 1件: 299 299 |
651 | IV tobramycin | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
652 | IV vancomycin hydrochloride | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 1件: 299 299 |
653 | IVA | - | - | - | - | 1件: 299 299 |
654 | IVACAFTOR | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
655 | Ivacaftor (proposed INN) | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
656 | Ivacaftor 125mg tablet | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
657 | Ivacaftor 150 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
658 | Ivacaftor 150 mg or 250 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
659 | Ivacaftor 25 mg/75 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
660 | IVACAFTOR 59,5mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
661 | IVACAFTOR 59.5mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
662 | Ivacaftor 75 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
663 | Ivacaftor 75 mg/150 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
664 | IVACAFTOR 75mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
665 | Ivacaftor Exposed | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
666 | Ivacaftor or elexacaftor/tezacaftor/ivacaftor | 3件: Elexacaftor Elexacaftor, Ivacaftor, Tezacaftor | 3件: D09916
D09916
,
D11041
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
667 | Ivacaftor+lumacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
668 | Ivacaftor/Ataluren | 2件: Ataluren Ataluren, Ivacaftor | 2件: D09323
D09323
,
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
669 | Ivacaftor/Kalydeco | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
670 | Ivacaftor/Trikafta | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
671 | J01GB01 | - | - | - | - | 1件: 299 299 |
672 | JBT-101 | - | - | - | - | 4件: 49 49, 50, 51, 299 |
673 | JBT-101 (lenabasum) | - | - | - | - | 1件: 299 299 |
674 | JBT101 | - | - | - | - | 1件: 299 299 |
675 | Kaftrio | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
676 | Kalydeco | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
677 | Kalydeco 150 mg film-c | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
678 | Kalydeco 150 mg film-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
679 | Kalydeco 150mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
680 | KB001 | 1件: KB001 KB001 | - | - | - | 1件: 299 299 |
681 | KB001-A | 1件: KB001 KB001 | - | - | - | 1件: 299 299 |
682 | KB407 (Nebulization) | - | - | - | - | 1件: 299 299 |
683 | Ketone Monoester | - | - | - | - | 1件: 299 299 |
684 | Kineret | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 9件: 28 28, 41, 46, 49, 65, 106, 107, 266, 299 |
685 | Klacid | - | - | - | - | 1件: 299 299 |
686 | Kreon 25 000 | - | - | - | - | 1件: 299 299 |
687 | Kreon 25,000 Units | - | - | - | - | 1件: 299 299 |
688 | Kreon 25000 | - | - | - | - | 2件: 298 298, 299 |
689 | KREON de Liberación Inmediata | - | - | - | - | 1件: 299 299 |
690 | KREON N 25000 | - | - | - | - | 1件: 299 299 |
691 | Kreon® 25,000 | - | - | - | - | 1件: 299 299 |
692 | L-alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 1件: 299 299 |
693 | L-arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 8件: 46 46, 67, 78, 96, 97, 98, 113, 299 |
694 | L-Glutamine | 1件: L-Glutamine L-Glutamine | 1件: D00015
D00015
| - | - | 2件: 113 113, 299 |
695 | L-Lysine N acetylcysteinate | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
696 | L-Lysine N-acetylcysteinate | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
697 | L-Lysine- N-acetylcysteinate | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
698 | L-Lysine-N-acetyl-L-cysteinate | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
699 | L-Lysine-N-acetylcysteinate | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 1件: 299 299 |
700 | LABA/LAMA | - | - | - | - | 1件: 299 299 |
701 | Lactic acid | 1件: Lactic acid Lactic acid | 1件: D00111
D00111
| - | - | 1件: 299 299 |
702 | Lactic acid producing organisms | 1件: Lactic acid Lactic acid | 1件: D00111
D00111
| - | - | 1件: 299 299 |
703 | Lactizole nebulization | - | - | - | - | 1件: 299 299 |
704 | Lactobacillus | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 5件: 6 6, 46, 51, 97, 299 |
705 | LACTOBACILLUS REUTERI | 1件: Lactobacillus reuteri Lactobacillus reuteri | - | - | - | 2件: 97 97, 299 |
706 | Lactobacillus rhamnosus | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 1件: 299 299 |
707 | Lactobacillus rhamnosus GG | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 1件: 299 299 |
708 | Lansoprazole | 1件: Lansoprazole Lansoprazole | 1件: D00355
D00355
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 7件: 63 63, 71, 85, 98, 166, 222, 299 |
709 | Lantus 100 units/ml solution for injection in a cartridge | - | - | - | - | 1件: 299 299 |
710 | LANTUS*SC 5CAR3ML100UI/ML | 1件: Insulin glargine Insulin glargine | 1件: D03250
D03250
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
711 | Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen | - | - | - | - | 1件: 299 299 |
712 | LAU-7b | - | - | - | - | 1件: 299 299 |
713 | Lefamulin | 1件: Lefamulin Lefamulin | 1件: D11631
D11631
| - | - | 1件: 299 299 |
714 | Lenabasum | - | - | - | - | 3件: 50 50, 51, 299 |
715 | Lenabasum 20 mg | - | - | - | - | 2件: 51 51, 299 |
716 | Lenabasum 5 mg | - | - | - | - | 2件: 51 51, 299 |
717 | Leucine | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 6件: 6 6, 19, 65, 283, 284, 299 |
718 | Levemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
719 | Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
720 | Levemir FlexPen | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
721 | Levemir Penfill | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
722 | Levofloxacin | 1件: Levofloxacin Levofloxacin | 2件: D00588
D00588
,
D08120
| - | - | 4件: 46 46, 53, 84, 299 |
723 | LEVOFLOXACIN HEMIHYDRATE | 1件: Levofloxacin Levofloxacin | 2件: D00588
D00588
,
D08120
| - | - | 1件: 299 299 |
724 | Levofloxacin Kabi | 1件: Levofloxacin Levofloxacin | 2件: D00588
D00588
,
D08120
| - | - | 1件: 299 299 |
725 | Linez | - | - | - | - | 1件: 299 299 |
726 | LINEZOLID | 1件: Linezolid Linezolid | 1件: D00947
D00947
| - | - | 1件: 299 299 |
727 | Linoleic acid | 1件: Linoleic acid Linoleic acid | - | - | - | 4件: 2 2, 5, 13, 299 |
728 | Linoleic acid supplementation | 1件: Linoleic acid Linoleic acid | - | - | - | 1件: 299 299 |
729 | LIPASA | - | - | - | - | 1件: 299 299 |
730 | LIPASE | - | - | - | - | 2件: 298 298, 299 |
731 | Lipase CLEC | - | - | - | - | 1件: 299 299 |
732 | LIPASE LIP2 | - | - | - | - | 1件: 299 299 |
733 | Lipase Lip2 from Yarrowia lipolytica | - | - | - | - | 1件: 299 299 |
734 | Lipitor | 1件: Atorvastatin Atorvastatin | 1件: D07474
D07474
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 51 51, 96, 299 |
735 | Liposomal Amikacin | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
736 | Liposomal Amikacin (Arikace TM) | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
737 | Liposomal Amikacin (Arikace™) | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
738 | Liposomal amikacin for inhalation | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
739 | Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
740 | Liposomal amphotericin B (Ambisome®) | 1件: Amphotericin B Amphotericin B | 1件: D00203
D00203
| - | - | 1件: 299 299 |
741 | Liprotamasa | - | - | - | - | 1件: 299 299 |
742 | Liprotamase | - | - | - | - | 2件: 298 298, 299 |
743 | Liprotamase Powder for Oral Solution | - | - | - | - | 1件: 299 299 |
744 | Loestrin (norethindrone acetate and ethinyl estradiol) | 3件: Acetate Acetate, Estradiol, Norethisterone | 2件: D00105
D00105
,
D00182
| 3件: ESR1 ESR1, ESR2, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 |
745 | Lonodelestat | - | - | - | - | 1件: 299 299 |
746 | Losartan | 1件: Losartan Losartan | 1件: D08146
D08146
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
747 | LU 70274 | - | - | - | - | 1件: 299 299 |
748 | LUBIPROSTONE | 1件: Lubiprostone Lubiprostone | 1件: D04790
D04790
| 1件: CLCN2 CLCN2 💬 | 1件: Mineral absorption Mineral absorption 💬 | 4件: 6 6, 13, 290, 299 |
749 | Lucinactant | 1件: Lucinactant Lucinactant | 1件: D04792
D04792
| - | - | 1件: 299 299 |
750 | Lucinactant first | 1件: Lucinactant Lucinactant | 1件: D04792
D04792
| - | - | 1件: 299 299 |
751 | LUM | - | - | - | - | 1件: 299 299 |
752 | LUM/IVA | - | - | - | - | 1件: 299 299 |
753 | LUM/IVA fixed-dose combination | - | - | - | - | 1件: 299 299 |
754 | LUMACAFTOR | 1件: Lumacaftor Lumacaftor | 1件: D10134
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
755 | Lumacaftor / ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
756 | Lumacaftor plus Ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
757 | Lumacaftor Plus Ivacaftor Combination | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
758 | Lumacaftor, Ivacaftor Drug Combination | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
759 | Lumacaftor-ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
760 | Lumacaftor-Ivacaftor treatment | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
761 | Lumacaftor/Ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
762 | Lumacaftor/ivacaftor 100mg/125mg tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
763 | Lumacaftor/ivacaftor 200mg/125mg | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
764 | Lumacaftor/ivacaftor 200mg/125mg tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
765 | Lumacaftor/ivacaftor 200mg/83mg tablet | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
766 | Lym-X-Sorb powder | - | - | - | - | 1件: 299 299 |
767 | Lysine | 1件: Lysine Lysine | 1件: D02304
D02304
| - | - | 4件: 13 13, 97, 228, 299 |
768 | Lysomucil 10 % | - | - | - | - | 1件: 299 299 |
769 | Macrogol | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 1件: 299 299 |
770 | Macrogol 4000 | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 1件: 299 299 |
771 | MAG-DHA | - | - | - | - | 1件: 299 299 |
772 | Mannite | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
773 | Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 7件: 6 6, 13, 28, 60, 96, 113, 299 |
774 | Mannitol + pulmozyme | 2件: Dornase alfa Dornase alfa, Mannitol | 2件: D00062
D00062
,
D03896
| - | - | 1件: 299 299 |
775 | Mannitol Inhalant Product | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
776 | Mannitol inhalation powder | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
777 | Matched isoglycemic clamp | - | - | - | - | 1件: 299 299 |
778 | Mecasermin | 1件: Mecasermin Mecasermin | 1件: D03297
D03297
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 5件: 78 78, 96, 168, 265, 299 |
779 | MEDI-563 | - | - | - | - | 5件: 44 44, 45, 98, 162, 299 |
780 | Medical Grade Oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 299 299 |
781 | Melphalan | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
782 | Menadiol Diphosphate | 1件: Menadiol diphosphate Menadiol diphosphate | 1件: D08176
D08176
| - | - | 1件: 299 299 |
783 | Menadiol sodium diphosphate | 1件: Kappadione Kappadione | 1件: D04908
D04908
| - | - | 1件: 299 299 |
784 | MEROPENEM | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 2件: 60 60, 299 |
785 | Meropenem Fresenius Kabi | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
786 | Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
787 | Meropenem Infusion | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
788 | MEROPENEM TRIHYDRATE | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
789 | Mesenchymal stem cells | - | - | - | - | 11件: 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
790 | Metformin | 1件: Metformin Metformin | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
791 | METFORMIN HYDROCHLORIDE | 1件: Metformin Metformin | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 5件: 81 81, 158, 265, 299, 301 |
792 | Metformine | 1件: Metformin Metformin | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 3件: 46 46, 81, 299 |
793 | Metformine HCL 500 PCH | 1件: Metformin Metformin | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 299 299 |
794 | Midazolam | 1件: Midazolam Midazolam | 1件: D00550
D00550
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 |
795 | MIGLUSTAT | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 19 19, 256, 299 |
796 | Minocycline | 1件: Minocycline Minocycline | 1件: D05045
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
797 | Minocycline Hydrochloride | 1件: Minocycline Minocycline | 1件: D05045
D05045
| - | - | 4件: 13 13, 201, 206, 299 |
798 | MMF | - | - | - | - | 16件: 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299 |
799 | Modified lipid formulation | - | - | - | - | 1件: 299 299 |
800 | Modified Oral Glucose Tolerance Test (50g 4-hours) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
801 | Molgramostim | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 3件: 97 97, 229, 299 |
802 | Molgramostim nebulizer solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 299 299 |
803 | MOLI 1901 | - | - | - | - | 1件: 299 299 |
804 | Moli 1901 (2622U90, duramycin) | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
805 | Moli1901 | - | - | - | - | 1件: 299 299 |
806 | Moli1901 (2622U90, duramycin) | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
807 | Moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 1件: D08237
D08237
| - | - | 9件: 2 2, 6, 46, 49, 85, 86, 113, 240, 299 |
808 | Moxifloxacin Hydrochloride | 1件: Moxifloxacin Moxifloxacin | 1件: D08237
D08237
| - | - | 2件: 113 113, 299 |
809 | MP-376 | - | - | - | - | 1件: 299 299 |
810 | MP-376 (Levofloxacin Solution for Inhalation) | 1件: Levofloxacin Levofloxacin | 2件: D00588
D00588
,
D08120
| - | - | 1件: 299 299 |
811 | MRI with PFP | - | - | - | - | 1件: 299 299 |
812 | MRT5005 | - | - | - | - | 1件: 299 299 |
813 | MS1819 | - | - | - | - | 2件: 298 298, 299 |
814 | MS1819-SD | 1件: MS-1819 MS-1819 | - | - | - | 2件: 298 298, 299 |
815 | MSI-1995 | - | - | - | - | 1件: 299 299 |
816 | MTT | - | - | - | - | 1件: 299 299 |
817 | Mucoid exopolysaccharide P. aeruginosa immune globulin IV | - | - | - | - | 1件: 299 299 |
818 | Mucolysin | - | - | - | - | 1件: 299 299 |
819 | Mucomyst | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
820 | Multienzymes (lipase, protease etc.) | - | - | - | - | 2件: 298 298, 299 |
821 | Mupirocin | 1件: Mupirocin Mupirocin | 1件: D01076
D01076
| - | - | 2件: 227 227, 299 |
822 | Mupirocin Intranasal Creme | 1件: Mupirocin Mupirocin | 1件: D01076
D01076
| - | - | 1件: 299 299 |
823 | N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide | - | - | - | - | 1件: 299 299 |
824 | N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide | - | - | - | - | 1件: 299 299 |
825 | N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide | - | - | - | - | 1件: 299 299 |
826 | N-acetylcystein | - | - | - | - | 1件: 299 299 |
827 | N-Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 13件: 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 |
828 | N-acetylcysteine (NAC) | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 2件: 51 51, 299 |
829 | N6022 | - | - | - | - | 1件: 299 299 |
830 | N91115 | - | - | - | - | 1件: 299 299 |
831 | NAC | - | - | - | - | 4件: 51 51, 85, 90, 299 |
832 | Nacystelyn | - | - | - | - | 1件: 299 299 |
833 | Nacystelyn® | - | - | - | - | 1件: 299 299 |
834 | NAL | - | - | - | - | 2件: 6 6, 299 |
835 | Nasal Aztreonam | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
836 | Navocaftor | - | - | - | - | 1件: 299 299 |
837 | NEB/01-07 | - | - | - | - | 1件: 299 299 |
838 | Nebcin | - | - | - | - | 1件: 299 299 |
839 | Nebcin (tobramycin) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
840 | Nebcinal | - | - | - | - | 1件: 299 299 |
841 | Nebcinal Tobi | - | - | - | - | 1件: 299 299 |
842 | NEBCINE | - | - | - | - | 1件: 299 299 |
843 | Nebulization of Amikacin during NIV (RR: 15 cycles/minute) | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
844 | Nebulization of Amikacin during NIV (RR: 25 cycles/minute) | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
845 | Nebulization tobramycin | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
846 | Nexium | 1件: Esomeprazole Esomeprazole | 1件: D07917
D07917
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 299 299 |
847 | Nexium 20 | 1件: Esomeprazole Esomeprazole | 1件: D07917
D07917
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 299 299 |
848 | Nitrate | 1件: Nitrate Nitrate | 1件: D02313
D02313
| - | - | 4件: 58 58, 67, 113, 299 |
849 | NITRIC OXIDE | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 7件: 85 85, 86, 88, 210, 251, 294, 299 |
850 | Nitric Oxide 160 ppm | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 1件: 299 299 |
851 | Nitric Oxide for inhalation | 1件: Nitric Oxide Nitric Oxide | 1件: D00074
D00074
| - | - | 2件: 86 86, 299 |
852 | Nitrogen | 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 5件: 5 5, 6, 17, 211, 299 |
853 | NO | - | - | - | - | 9件: 6 6, 46, 58, 62, 86, 97, 222, 299, 321 |
854 | None | - | - | - | - | 20件: 6 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337 |
855 | None assigned | 1件: Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | 2件: 231 231, 299 |
856 | Norethindrone | 1件: Norethisterone Norethisterone | 1件: D00182
D00182
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 4件: 13 13, 46, 49, 299 |
857 | Norgestimate | 1件: Norgestimate Norgestimate | 1件: D05209
D05209
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 299 299 |
858 | Normal Saline | - | - | - | - | 18件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
859 | Normal saline IV, salt tablets | - | - | - | - | 1件: 299 299 |
860 | Normal saline solution | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
861 | Normal saline: | - | - | - | - | 1件: 299 299 |
862 | Norvir | 1件: Ritonavir Ritonavir | 1件: D00427
D00427
| - | - | 2件: 265 265, 299 |
863 | Norvir 100 mg film-coated tablets | - | - | - | - | 1件: 299 299 |
864 | Novamin | - | - | - | - | 1件: 299 299 |
865 | Novo Rapid | - | - | - | - | 1件: 299 299 |
866 | Novo Rapid Insulin (Novonordisk) | - | - | - | - | 1件: 299 299 |
867 | NovoNorm 0.5 mg | - | - | - | - | 1件: 299 299 |
868 | NovoNorm 1 mg | - | - | - | - | 1件: 299 299 |
869 | NovoNorm 2 mg | - | - | - | - | 1件: 299 299 |
870 | Novorapid / humalog short acting insulin | - | - | - | - | 1件: 299 299 |
871 | NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen. | - | - | - | - | 1件: 299 299 |
872 | NovoRapid Aspartate | - | - | - | - | 1件: 299 299 |
873 | Noxafil | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 3件: 60 60, 65, 299 |
874 | NOXAFIL - 40 mg/ml oral suspension | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
875 | NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
876 | NOXAFIL - oral suspension 40 mg/ml | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
877 | Noxafil 100 mg | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
878 | Noxafil 100 mg Tablets Gastro-Resistant | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
879 | Noxafil® | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 2件: 60 60, 299 |
880 | Nutridrink-Impact | - | - | - | - | 1件: 299 299 |
881 | Nutropin AQ | - | - | - | - | 4件: 78 78, 134, 193, 299 |
882 | Nutropin AQ [somatropin (DNA origin) injection] | 1件: Somatotropin Somatotropin | - | - | - | 1件: 299 299 |
883 | OGT 918 | - | - | - | - | 2件: 19 19, 299 |
884 | Oleic Acid | 1件: Oleic Acid Oleic Acid | 1件: D02315
D02315
| - | - | 2件: 13 13, 299 |
885 | Oleic acid supplementation | 1件: Oleic Acid Oleic Acid | 1件: D02315
D02315
| - | - | 1件: 299 299 |
886 | OligoG | - | - | - | - | 1件: 299 299 |
887 | OligoG (60 mg/ml) | - | - | - | - | 1件: 299 299 |
888 | OLIGOG CF-5/20 | - | - | - | - | 1件: 299 299 |
889 | OligoG CF-5/20 - 17.5 mg | - | - | - | - | 1件: 299 299 |
890 | OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | 1件: 299 299 |
891 | OligoG CF/20 - 27.5 mg | - | - | - | - | 1件: 299 299 |
892 | OligoG CF/20 - 37.5 mg | - | - | - | - | 1件: 299 299 |
893 | OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | 1件: 299 299 |
894 | OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation | - | - | - | - | 1件: 299 299 |
895 | OligoG DPI | - | - | - | - | 1件: 299 299 |
896 | OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 299 299 |
897 | Oligomer of Sodium Alginate | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 299 299 |
898 | Omadacycline | 1件: Omadacycline Omadacycline | 1件: D09647
D09647
| - | - | 1件: 299 299 |
899 | Omadacycline Injection [Nuzyra] | 1件: Omadacycline Omadacycline | 1件: D09647
D09647
| - | - | 1件: 299 299 |
900 | Omadacycline Oral Tablet [Nuzyra] | 1件: Omadacycline Omadacycline | 1件: D09647
D09647
| - | - | 1件: 299 299 |
901 | OMALIZUMAB | 1件: Omalizumab Omalizumab | 1件: D05251
D05251
| 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 7件: 46 46, 53, 65, 98, 162, 226, 299 |
902 | Omega 3 | - | - | - | - | 3件: 13 13, 53, 299 |
903 | Omega 3 Premium | - | - | - | - | 1件: 299 299 |
904 | Omega-3 | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 7件: 13 13, 46, 49, 66, 79, 96, 299 |
905 | Omega-3 triglycerides | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 299 299 |
906 | OMEGA-3-ACID TRIGLYCERIDES | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 299 299 |
907 | Omeprazole | 1件: Omeprazole Omeprazole | 1件: D00455
D00455
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 14件: 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 |
908 | Omeprazole 40mg Capsule | 1件: Omeprazole Omeprazole | 1件: D00455
D00455
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 299 299 |
909 | Once-daily insulin detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
910 | Oral Aztreonam | 1件: Aztreonam Aztreonam | 1件: D00240
D00240
| - | - | 1件: 299 299 |
911 | Oral ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
912 | Oral ciprofloxacin plus inhaled colistin | 2件: Ciprofloxacin Ciprofloxacin, Colistin | 2件: D00186
D00186
,
D07746
| - | - | 1件: 299 299 |
913 | Oral Glucose Tolerance test (75g 2-hour) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
914 | Oral Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
915 | Oral reduced l-glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
916 | Oral roflumilast | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 299 299 |
917 | Orkambi | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
918 | Orkambi 100 mg/125 mg film-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
919 | Orkambi 200 mg/125 mg film-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
920 | Orkambi: contains lumacaftor and ivacaftor | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: D09916
D09916
,
D10134
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
921 | Orkambi® | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
922 | Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg | 3件: Estradiol Estradiol, Ethinylestradiol, Norgestimate | 3件: D00105
D00105
,
D00554
,
D05209
| 3件: ESR1 ESR1, ESR2, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 |
923 | OSCN- | - | - | - | - | 1件: 299 299 |
924 | Oseltamivir | 1件: Oseltamivir Oseltamivir | 1件: D08306
D08306
| - | - | 2件: 97 97, 299 |
925 | Osmohale | - | - | - | - | 1件: 299 299 |
926 | Other non-sponsor pancreatic enzyme replacement therapy | - | - | - | - | 1件: 299 299 |
927 | Other respiratory system products | - | - | - | - | 1件: 299 299 |
928 | Oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 13件: 6 6, 49, 70, 85, 86, 88, 90, 96, 168, 193, 271, 299, 330 |
929 | P-1037 | - | - | - | - | 1件: 299 299 |
930 | PAAG15 | - | - | - | - | 1件: 299 299 |
931 | Pancreas Powder | - | - | - | - | 1件: 299 299 |
932 | Pancrease | - | - | - | - | 1件: 299 299 |
933 | PANCREASE MT | - | - | - | - | 1件: 299 299 |
934 | Pancrease MT 10.5, or MT 21 | - | - | - | - | 1件: 299 299 |
935 | PANCREASLIPASE | - | - | - | - | 1件: 299 299 |
936 | Pancreatin | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 2件: 298 298, 299 |
937 | PANCREATIN (PAncreas Powder) | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
938 | PANCREATINA | - | - | - | - | 1件: 299 299 |
939 | PANCREATINA (Páncreas Polvo | - | - | - | - | 1件: 299 299 |
940 | PANCREATINA (Páncreas Polvo) | - | - | - | - | 1件: 299 299 |
941 | PANCREAZE | - | - | - | - | 1件: 299 299 |
942 | PANCREAZE® | - | - | - | - | 1件: 299 299 |
943 | PANCRECARB® (pancrelipase) | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
944 | Pancrelipase | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 2件: 298 298, 299 |
945 | PANCRELIPASE AMYLASE | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
946 | Pancrelipase Delayed Release | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
947 | Pancrelipase Delayed Release Capsule | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 2件: 298 298, 299 |
948 | Pancrelipase Microtablets | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
949 | Pancrelipase with bicarbonate | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
950 | Pancrelipase/Pancreas Powder | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 2件: 298 298, 299 |
951 | Pankreatin | - | - | - | - | 1件: 299 299 |
952 | PANZYTRAT 25000 | - | - | - | - | 1件: 299 299 |
953 | Panzytrat® 25,000 | - | - | - | - | 1件: 299 299 |
954 | Panzytrat® ok | - | - | - | - | 1件: 299 299 |
955 | PBI4050 | - | - | - | - | 2件: 85 85, 299 |
956 | PC945 | - | - | - | - | 1件: 299 299 |
957 | PEG | - | - | - | - | 15件: 6 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337 |
958 | Perfluorinated gas/oxygen mixture | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 299 299 |
959 | PERTZYE | - | - | - | - | 1件: 299 299 |
960 | PFP | - | - | - | - | 1件: 299 299 |
961 | PGM169/GL67A | - | - | - | - | 1件: 299 299 |
962 | PGT-1 gene lipid complex | - | - | - | - | 1件: 299 299 |
963 | PHENYLBUTYRATE | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 12件: 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
964 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 32件: 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
965 | Physiologic serum nebulized nasally | - | - | - | - | 1件: 299 299 |
966 | Physiological solution | - | - | - | - | 1件: 299 299 |
967 | Pilocarpine | 1件: Pilocarpine Pilocarpine | 1件: D00525
D00525
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 53, 299 |
968 | Pilocarpine Nitrate 5% | 2件: Nitrate Nitrate, Pilocarpine | 2件: D00525
D00525
,
D02313
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
969 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 1件: D08378
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
970 | PIPERACILLIN | 1件: Piperacillin Piperacillin | 2件: D02251
D02251
,
D08380
| - | - | 1件: 299 299 |
971 | PIPERACILLIN SODIUM | 1件: Piperacillin Piperacillin | 2件: D02251
D02251
,
D08380
| - | - | 1件: 299 299 |
972 | Piperacillin sodium , tazobactam sodium | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
973 | Piperacillin with Tazobactam (tazocin) | 1件: Piperacillin Piperacillin | 2件: D02251
D02251
,
D08380
| - | - | 1件: 299 299 |
974 | Piperacillin-tazobactam combination product | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
975 | Piperacillin/Tazobactam | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
976 | Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria | 2件: Piperacillin Piperacillin, Tazobactam | 3件: D00660
D00660
,
D02251
,
D08380
| - | - | 1件: 299 299 |
977 | Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie | 1件: Tazobactam Tazobactam | 1件: D00660
D00660
| - | - | 1件: 299 299 |
978 | Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie | 1件: Tazobactam Tazobactam | 1件: D00660
D00660
| - | - | 1件: 299 299 |
979 | PL 0010/0211 | - | - | - | - | 1件: 299 299 |
980 | PLERIXAFOR | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 14件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 4件: 20 20, 65, 285, 299 |
981 | Plerixafor mobilization of autologous CD117 stem cells | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 14件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 299 299 |
982 | PO azithromycin | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
983 | PO ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 1件: D00186
D00186
| - | - | 1件: 299 299 |
984 | POL6014 | - | - | - | - | 1件: 299 299 |
985 | POL7080 | - | - | - | - | 1件: 299 299 |
986 | Polyethylene glycol | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 7件: 6 6, 78, 96, 97, 235, 276, 299 |
987 | Polyethylene Glycol 3350 | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 2件: 96 96, 299 |
988 | Porcine (pig) PERT | - | - | - | - | 1件: 299 299 |
989 | Porcine PERT | - | - | - | - | 1件: 299 299 |
990 | Posaconazole | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 3件: 60 60, 65, 299 |
991 | Posaconazole 100 MG [Noxafil] | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
992 | Posaconazole 40 MG/ML | 1件: Posaconazole Posaconazole | 1件: D02555
D02555
| - | - | 1件: 299 299 |
993 | POSACONAZOLO | - | - | - | - | 1件: 299 299 |
994 | PPI treatment | - | - | - | - | 1件: 299 299 |
995 | PREDNISOLONE | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
996 | Prednisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
997 | PREFOLIC*30CPR GASTROR 15MG | - | - | - | - | 1件: 299 299 |
998 | Probiotic | - | - | - | - | 8件: 2 2, 6, 93, 96, 97, 193, 266, 299 |
999 | Progesterone | 1件: Progesterone Progesterone | 1件: D00066
D00066
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 2件: 76 76, 299 |
1000 | Prograft capsules | - | - | - | - | 1件: 299 299 |
1001 | Prolastin | - | - | - | - | 3件: 231 231, 298, 299 |
1002 | Prolastin (drug) | - | - | - | - | 1件: 299 299 |
1003 | Promixin | - | - | - | - | 1件: 299 299 |
1004 | Promixin 1 million International Units (IU) Powder for Nebuliser Solution | - | - | - | - | 1件: 299 299 |
1005 | PROMIXIN*NEBUL 30MONOD 1MUI | - | - | - | - | 1件: 299 299 |
1006 | Promixin, 1 million International Units (IU) Powder for Nebuliser Solution | - | - | - | - | 1件: 299 299 |
1007 | Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador | - | - | - | - | 1件: 299 299 |
1008 | Promixin/Tadim | - | - | - | - | 1件: 299 299 |
1009 | PROTEASA | - | - | - | - | 1件: 299 299 |
1010 | PROTEASE | - | - | - | - | 1件: 299 299 |
1011 | PsAer IgY | - | - | - | - | 1件: 299 299 |
1012 | PTC-0161480 | - | - | - | - | 2件: 246 246, 299 |
1013 | PTC-124 | - | - | - | - | 2件: 246 246, 299 |
1014 | PTC-C124 | - | - | - | - | 2件: 246 246, 299 |
1015 | PTC124 | - | - | - | - | 4件: 19 19, 113, 246, 299 |
1016 | PTI-428 | 1件: PTI-428 PTI-428 | - | - | - | 1件: 299 299 |
1017 | PTI-801 | 1件: PTI-801 PTI-801 | - | - | - | 1件: 299 299 |
1018 | PTI-808 | - | - | - | - | 1件: 299 299 |
1019 | Pulmaquin® | - | - | - | - | 1件: 299 299 |
1020 | Pulmozyme | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
1021 | Pulmozyme (dornase alfa) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
1022 | Pulmozyme (Dornase alpha) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
1023 | Pulmozyme single use ampule | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
1024 | Pulmozyme® | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
1025 | PUR118 | - | - | - | - | 1件: 299 299 |
1026 | QAU145 | - | - | - | - | 1件: 299 299 |
1027 | QBW251 | - | - | - | - | 1件: 299 299 |
1028 | QBW276 | - | - | - | - | 1件: 299 299 |
1029 | QBW276 1500mcg | - | - | - | - | 1件: 299 299 |
1030 | QBW276 300mcg | - | - | - | - | 1件: 299 299 |
1031 | QBW276 Succinate | - | - | - | - | 1件: 299 299 |
1032 | QR-010 | - | - | - | - | 1件: 299 299 |
1033 | R03AC02 | - | - | - | - | 1件: 299 299 |
1034 | R03CC02 | - | - | - | - | 1件: 299 299 |
1035 | R05C B01 | - | - | - | - | 1件: 299 299 |
1036 | Radiolabelled OligoG CF-5/20 6% Solution | - | - | - | - | 1件: 299 299 |
1037 | Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation | - | - | - | - | 1件: 299 299 |
1038 | Radiolabelled OligoG CF-5/20 DPI | - | - | - | - | 1件: 299 299 |
1039 | Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI) | - | - | - | - | 1件: 299 299 |
1040 | Rapeglinide | - | - | - | - | 1件: 299 299 |
1041 | RAVICTI | 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 1件: D10127
D10127
| - | - | 2件: 251 251, 299 |
1042 | Ravicti high dose | 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 1件: D10127
D10127
| - | - | 1件: 299 299 |
1043 | Ravicti low dose | 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 1件: D10127
D10127
| - | - | 1件: 299 299 |
1044 | Recombiant human Desoxyribonuclease ( rhDNase) | 1件: Desoxyribonuclease Desoxyribonuclease | - | - | - | 1件: 299 299 |
1045 | Recombinant Human DNase (Pulmozyme) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
1046 | Recombinant human IGF-1 | - | - | - | - | 2件: 78 78, 299 |
1047 | Recombinant humanized monoclonal antibody omalizumab to IgE | 1件: Omalizumab Omalizumab | 1件: D05251
D05251
| 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 299 299 |
1048 | Recombinant truncated SPINT2 protease inhibitor | - | - | - | - | 1件: 299 299 |
1049 | Red Blood Cell Zn | - | - | - | - | 1件: 299 299 |
1050 | Reduced Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
1051 | Reduced glutathione sodium salt | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 299 299 |
1052 | Release | 1件: Manganese citrate Manganese citrate | - | - | - | 12件: 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
1053 | Relebactam | 1件: Relebactam Relebactam | 1件: D10726
D10726
| - | - | 1件: 299 299 |
1054 | Repaglinide | 1件: Repaglinide Repaglinide | 1件: D00594
D00594
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 4件: 6 6, 21, 46, 299 |
1055 | Repaglinide and Insulin | 1件: Repaglinide Repaglinide | 1件: D00594
D00594
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 299 299 |
1056 | Reparixin | 1件: Reparixin Reparixin | 1件: D08984
D08984
| 2件: CXCR1 CXCR1, CXCR2 💬 | 7件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 298 298, 299 |
1057 | Resunab, ajulemic acid, anabasum | 1件: Ajulemic acid Ajulemic acid | 1件: D11312
D11312
| 1件: CNR2 CNR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 50 50, 51, 299 |
1058 | RhBSSL | 1件: Bucelipase alfa Bucelipase alfa | - | - | - | 1件: 299 299 |
1059 | RhDNAse | - | - | - | - | 1件: 299 299 |
1060 | Rifampicin | 1件: Rifampicin Rifampicin | 1件: D00211
D00211
| - | - | 6件: 6 6, 17, 46, 93, 299, 338 |
1061 | Rifampin | 1件: Rifampicin Rifampicin | 1件: D00211
D00211
| - | - | 5件: 6 6, 13, 84, 86, 299 |
1062 | Rifaximin | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 8件: 6 6, 65, 93, 96, 97, 99, 296, 299 |
1063 | Rifaximin 550 MG Oral Tablet [XIFAXAN] | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 1件: 299 299 |
1064 | Rimactan | - | - | - | - | 1件: 299 299 |
1065 | RIOCIGUAT | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 6件: 51 51, 84, 86, 88, 225, 299 |
1066 | Riociguat (Adempas, BAY63-2521) | 1件: Riociguat Riociguat | 1件: D09572
D09572
| 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 4件: 51 51, 86, 88, 299 |
1067 | Roflumilast | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 4件: 84 84, 97, 206, 299 |
1068 | Roflumilast Oral Tablet | 1件: Roflumilast Roflumilast | 1件: D05744
D05744
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 299 299 |
1069 | Roscovitine | - | - | - | - | 1件: 299 299 |
1070 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 1件: D08492
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
1071 | ROSUVASTATIN CALCIUM | 2件: Calcium Calcium, Rosuvastatin | 1件: D08492
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 4件: 49 49, 79, 97, 299 |
1072 | Roxithromycin | 1件: Roxithromycin Roxithromycin | 1件: D01710
D01710
| - | - | 2件: 46 46, 299 |
1073 | RPL554 | - | - | - | - | 1件: 299 299 |
1074 | RPS 2505 | - | - | - | - | 2件: 246 246, 299 |
1075 | Répaglinide | - | - | - | - | 1件: 299 299 |
1076 | S-1226 | - | - | - | - | 1件: 299 299 |
1077 | Salbutamol | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 3 3, 11, 49, 85, 86, 111, 256, 299 |
1078 | Salbutamol-ratiopharm® N metered-dose aerosol inhaler | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1079 | Salbutamol-ratiopharm® N metereddose aerosol inhaler | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1080 | Salbutamolo | - | - | - | - | 1件: 299 299 |
1081 | Saline | - | - | - | - | 10件: 6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 |
1082 | Saline 0.9% inhalation solution | - | - | - | - | 1件: 299 299 |
1083 | Saline solution | - | - | - | - | 4件: 2 2, 34, 288, 299 |
1084 | Salmeterol | 1件: Salmeterol Salmeterol | 1件: D05792
D05792
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1085 | Saxagliptin | 1件: Saxagliptin Saxagliptin | 1件: D08996
D08996
| 1件: DPP4 DPP4 💬 | 1件: Protein digestion and absorption Protein digestion and absorption 💬 | 1件: 299 299 |
1086 | SB-656933 Tablets | - | - | - | - | 2件: 97 97, 299 |
1087 | SB-656933-AAA | - | - | - | - | 1件: 299 299 |
1088 | SB656933 | - | - | - | - | 1件: 299 299 |
1089 | SE10599 | - | - | - | - | 1件: 299 299 |
1090 | Seliciclib | 1件: Seliciclib Seliciclib | - | - | - | 2件: 75 75, 299 |
1091 | Serum Zn | - | - | - | - | 1件: 299 299 |
1092 | SF6 | - | - | - | - | 1件: 299 299 |
1093 | Short-acting Insulin (Actrapid) | - | - | - | - | 1件: 299 299 |
1094 | Sildenafil | 1件: Sildenafil Sildenafil | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
1095 | Sildenafil (Acute-1 hour) | 1件: Sildenafil Sildenafil | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1096 | Sildenafil (Subchronic-4 weeks) | 1件: Sildenafil Sildenafil | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1097 | Sildenafil 40mg oral capsule | 1件: Sildenafil Sildenafil | 1件: D08514
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1098 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
1099 | Simvastatin treatment for 28 days | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 299 299 |
1100 | SIN ASIGNAR | - | - | - | - | 1件: 299 299 |
1101 | Sitagliptin | 1件: Sitagliptin Sitagliptin | 1件: D08516
D08516
| 1件: DPP4 DPP4 💬 | 1件: Protein digestion and absorption Protein digestion and absorption 💬 | 4件: 6 6, 75, 233, 299 |
1102 | SLIT Amikacin | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
1103 | SLIT(TM) Amikacin | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
1104 | SMX | - | - | - | - | 1件: 299 299 |
1105 | SNSP113 | - | - | - | - | 1件: 299 299 |
1106 | Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca | - | - | - | - | 1件: 299 299 |
1107 | Sodium 4-Phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 1件: 299 299 |
1108 | Sodium 4-Phenylbutyrate (4PBA) | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 1件: 299 299 |
1109 | SODIUM ALGINATE | 1件: Alginic acid Alginic acid | 1件: D02324
D02324
| - | - | 1件: 299 299 |
1110 | Sodium Bicarbonate | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: D01203
D01203
| - | - | 1件: 299 299 |
1111 | SODIUM BICARBONATE BP | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: D01203
D01203
| - | - | 1件: 299 299 |
1112 | Sodium chloride | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 |
1113 | Sodium chloride (7%) | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
1114 | Sodium chloride 0,9% | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
1115 | Sodium chloride 6% | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
1116 | SODIUM CHLORIDE 7% | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
1117 | SODIUM CHLORIDE PH. EUR. | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
1118 | SODIUM CHLORIDE SOLUTION 0.9% | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 4件: 51 51, 60, 288, 299 |
1119 | Sodium Fusidate | 1件: Fusidic acid Fusidic acid | 1件: D04281
D04281
| - | - | 1件: 299 299 |
1120 | Sodium Pyruvate in 0.9% Sodium Chloride Solution | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 299 299 |
1121 | Soluble fiber supplementation | - | - | - | - | 1件: 299 299 |
1122 | Somalgen | - | - | - | - | 1件: 299 299 |
1123 | Somatropin | 1件: Somatotropin Somatotropin | - | - | - | 19件: 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
1124 | SPI-1005 Ebselen 200mg Capsule x1 | 1件: Ebselen Ebselen | - | - | - | 1件: 299 299 |
1125 | SPI-1005 Ebselen 200mg Capsule x2 | 1件: Ebselen Ebselen | - | - | - | 1件: 299 299 |
1126 | SPI-1005 Ebselen 200mg Capsule x3 | 1件: Ebselen Ebselen | - | - | - | 1件: 299 299 |
1127 | Spiriva | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1128 | Spiriva Respimat | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1129 | Spiriva Respimat 2.5 mcg | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1130 | Spiriva Respimat 2.5 microgram | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1131 | Spiriva Respimat 2.5 microgram, solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1132 | Sporanox | 1件: Itraconazole Itraconazole | 1件: D00350
D00350
| - | - | 2件: 227 227, 299 |
1133 | Sporanox 10 mg/ml Oral Solution | 1件: Itraconazole Itraconazole | 1件: D00350
D00350
| - | - | 1件: 299 299 |
1134 | Sputum | - | - | - | - | 1件: 299 299 |
1135 | SPX-101 | - | - | - | - | 1件: 299 299 |
1136 | Ss-Adrenergic cocktail | - | - | - | - | 1件: 299 299 |
1137 | Standard Care | - | - | - | - | 2件: 81 81, 299 |
1138 | Standard Dose YPT-01 | - | - | - | - | 1件: 299 299 |
1139 | Standard Formula | - | - | - | - | 1件: 299 299 |
1140 | Standard formula (Enfamil) | - | - | - | - | 1件: 299 299 |
1141 | Standard Nutritional Supplement + PERT | - | - | - | - | 1件: 299 299 |
1142 | Standard of care IV antibiotic(s) | - | - | - | - | 1件: 299 299 |
1143 | Standardized turmeric root extract | 1件: Turmeric Turmeric | - | - | - | 1件: 299 299 |
1144 | STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V) | - | - | - | - | 1件: 299 299 |
1145 | Study medication, azithromycin | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
1146 | SUB185183 | - | - | - | - | 1件: 299 299 |
1147 | Sulfamethoxazole | 1件: Sulfamethoxazole Sulfamethoxazole | 1件: D00447
D00447
| - | - | 5件: 44 44, 49, 61, 85, 299 |
1148 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
1149 | Sulfato de amikacina | 1件: Amikacin Amikacin | 1件: D02543
D02543
| - | - | 1件: 299 299 |
1150 | Sulfur Colloid | 1件: Gelatin Gelatin | 2件: D00115
D00115
,
D06892
| - | - | 1件: 299 299 |
1151 | Sunflower oil | 1件: Sunflower oil Sunflower oil | 1件: D09006
D09006
| - | - | 2件: 46 46, 299 |
1152 | Supplementation with vitamin D2/D3 | 1件: Ergocalciferol Ergocalciferol | 1件: D00187
D00187
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
1153 | Symbiotic Formula with DHA and antioxidants | - | - | - | - | 1件: 299 299 |
1154 | Symdeko | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1155 | Symdeko/Trikafta | 2件: Elexacaftor Elexacaftor, Ivacaftor | 2件: D09916
D09916
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1156 | Symkevi | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1157 | Symkevi 100mg/150mg Film-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1158 | Synrinse | - | - | - | - | 1件: 299 299 |
1159 | T 100 PARI | - | - | - | - | 1件: 299 299 |
1160 | T-326 | - | - | - | - | 1件: 299 299 |
1161 | T100 | - | - | - | - | 1件: 299 299 |
1162 | T100 PARI | - | - | - | - | 1件: 299 299 |
1163 | Ta1 | - | - | - | - | 1件: 299 299 |
1164 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
1165 | Tacrolimus and MMF | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1166 | Tacrolimus Capsules | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 222 222, 299 |
1167 | Tacrolimus prolonged-release hard capsules | 2件: Manganese citrate Manganese citrate, Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1168 | Tad | - | - | - | - | 1件: 299 299 |
1169 | TAD 600 | - | - | - | - | 1件: 299 299 |
1170 | Tadim | - | - | - | - | 1件: 299 299 |
1171 | TAFLUPROST | 1件: Tafluprost Tafluprost | 1件: D06274
D06274
| 1件: PTGFR PTGFR 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 | 1件: 299 299 |
1172 | Talniflumate | 1件: Talniflumate Talniflumate | 1件: D02701
D02701
| - | - | 1件: 299 299 |
1173 | TAUROURSODEOXYCHOLIC ACID | 1件: Tauroursodeoxycholic acid Tauroursodeoxycholic acid | 1件: D11836
D11836
| - | - | 3件: 2 2, 93, 299 |
1174 | TAZOBACTAM | 1件: Tazobactam Tazobactam | 1件: D00660
D00660
| - | - | 1件: 299 299 |
1175 | TAZOBACTAM SODIUM | 1件: Tazobactam Tazobactam | 1件: D00660
D00660
| - | - | 1件: 299 299 |
1176 | TBD | - | - | - | - | 5件: 19 19, 86, 90, 276, 299 |
1177 | TBM100 | - | - | - | - | 1件: 299 299 |
1178 | TBM100C | - | - | - | - | 1件: 299 299 |
1179 | Technetium Sulfur Colloid | 1件: Gelatin Gelatin | 2件: D00115
D00115
,
D06892
| - | - | 1件: 299 299 |
1180 | Tedizolid | 1件: Tedizolid Tedizolid | 1件: D09685
D09685
| - | - | 1件: 299 299 |
1181 | Tedizolid IV | 1件: Tedizolid Tedizolid | 1件: D09685
D09685
| - | - | 1件: 299 299 |
1182 | Tedizolid PO | 1件: Tedizolid Tedizolid | 1件: D09685
D09685
| - | - | 1件: 299 299 |
1183 | Tefibazumab | 1件: Tefibazumab Tefibazumab | 1件: D06054
D06054
| - | - | 1件: 299 299 |
1184 | Teicoplanin | 1件: Teicoplanin Teicoplanin | 1件: D02142
D02142
| - | - | 2件: 70 70, 299 |
1185 | Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. | 1件: Teicoplanin Teicoplanin | 1件: D02142
D02142
| - | - | 1件: 299 299 |
1186 | Telavancin | 1件: Telavancin Telavancin | - | - | - | 1件: 299 299 |
1187 | Telavancin Injection | 1件: Telavancin Telavancin | - | - | - | 1件: 299 299 |
1188 | TERLIPRESSIN | 1件: Terlipressin Terlipressin | 1件: D06672
D06672
| 3件: AVPR1A AVPR1A, AVPR1B, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 299 299 |
1189 | Terlipressin acetate | 2件: Acetate Acetate, Terlipressin | 1件: D06672
D06672
| 3件: AVPR1A AVPR1A, AVPR1B, AVPR2 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 299 299 |
1190 | TEZ | - | - | - | - | 1件: 299 299 |
1191 | TEZ/IVA | - | - | - | - | 1件: 299 299 |
1192 | TEZACAFTOR | 1件: Tezacaftor Tezacaftor | 1件: D11041
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1193 | Tezacaftor (TEZ) | 1件: Tezacaftor Tezacaftor | 1件: D11041
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1194 | Tezacaftor/Ivacaftor | 2件: Ivacaftor Ivacaftor, Tezacaftor | 2件: D09916
D09916
,
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1195 | Tezacaftor/Ivacaftor + Ivacaftor | 2件: Ivacaftor Ivacaftor, Tezacaftor | 2件: D09916
D09916
,
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1196 | Tezacaftor/Ivacaftor 100mg/150mg | 2件: Ivacaftor Ivacaftor, Tezacaftor | 2件: D09916
D09916
,
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1197 | Tezacaftor/Ivacaftor/100mg/150mg | 2件: Ivacaftor Ivacaftor, Tezacaftor | 2件: D09916
D09916
,
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1198 | TgAAVCF | - | - | - | - | 1件: 299 299 |
1199 | Tham | 1件: Tromethamine Tromethamine | 1件: D00396
D00396
| - | - | 1件: 299 299 |
1200 | The gut mycobiota and microbiota profile | - | - | - | - | 1件: 299 299 |
1201 | The lung mycobiota and microbiota profile | - | - | - | - | 1件: 299 299 |
1202 | Theophylline | 1件: Theophylline Theophylline | 2件: D00371
D00371
,
D06103
| 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 236 236, 299 |
1203 | Thymosin alpha 1 | - | - | - | - | 1件: 299 299 |
1204 | Ticarcillin | 1件: Ticarcillin Ticarcillin | 1件: D08593
D08593
| - | - | 1件: 299 299 |
1205 | Tigerase® | - | - | - | - | 1件: 299 299 |
1206 | Tiotropium | 1件: Tiotropium Tiotropium | - | - | - | 3件: 55 55, 85, 299 |
1207 | Tiotropium bromide | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1208 | Tiotropium Bromide (monohydrate) | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1209 | Tiotropium bromide 5 mcg | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1210 | Tiotropium bromide high | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1211 | Tiotropium bromide low | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1212 | Tiotropium bromide medium | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1213 | TIOTROPIUM BROMIDE MONOHYDRATE | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1214 | Tiotropium bromide-low dose-2.5mcg | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1215 | Tiotropium Respimat | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1216 | Tiotropium Respimat 1.25 microgram solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1217 | Tiotropium Respimat 1.25 microgram, solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1218 | Tiotropium Respimat 1.25 micrograms solution for inhalation | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1219 | Tiotropium Respimat® inhaler | 1件: Tiotropium Tiotropium | - | - | - | 1件: 299 299 |
1220 | TIP | - | - | - | - | 1件: 299 299 |
1221 | TIP (Tobramycin inhalation powder) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1222 | TIS (Tobramycin Inhalation Solution) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1223 | TIS or TIP | - | - | - | - | 1件: 299 299 |
1224 | TMP | 1件: TMP TMP | - | - | - | 1件: 299 299 |
1225 | TNSE | - | - | - | - | 1件: 299 299 |
1226 | TOBI | - | - | - | - | 1件: 299 299 |
1227 | TOBI (tobramycin) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1228 | TOBI 300 mg / 5 mL nebuliser solution | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1229 | TOBI 300 mg/5 ml Lösung für einen | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1230 | TOBI 300 mg/5 ml Lösung für einen Vernebler | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1231 | TOBI 300 mg/5 ml Nebuliser Solution | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1232 | TOBI 300 mg/5 ml solución para inhalación por nebulizador | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1233 | TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1234 | TOBI 300mg/ 5ml solución para inhalación con nebulizador | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1235 | TOBI 300mg/5mL Nebuliser Solution | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1236 | Tobi 300mg/5ml Nebuliser solution. | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1237 | Tobi 300mg/5ml Solución para inhalación por nebulizador. | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1238 | Tobi Inhalant Product | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1239 | Tobi Nebcinal | - | - | - | - | 1件: 299 299 |
1240 | TOBI PODHALER | - | - | - | - | 1件: 299 299 |
1241 | TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1242 | TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1243 | TOBI Podhaler 28 mg inhalációs por, kemény kapszula | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1244 | TOBI PODHALER*448CPS 28MG+10IN | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1245 | TOBI*NEBUL 56F 1D 300MG/5ML | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1246 | TOBI® | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1247 | TOBI™ Podhaler™ 112 mg inhaled twice daily | - | - | - | - | 1件: 299 299 |
1248 | Tobramcyin | - | - | - | - | 1件: 299 299 |
1249 | TOBRAMICINA | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1250 | Tobramicina polvere inalatoria | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1251 | TOBRAMICINA SOLFATO | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1252 | Tobramicyn | - | - | - | - | 1件: 299 299 |
1253 | TOBRAMYCIN | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1254 | Tobramycin (Gernebcin®) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1255 | Tobramycin / Bramitob | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1256 | Tobramycin / TOBI | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1257 | Tobramycin 100 PARI | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1258 | Tobramycin dry powder | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1259 | Tobramycin for Inhalation | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1260 | Tobramycin Inhalation Powder | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1261 | Tobramycin Inhalation Powder (TIP) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1262 | Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1263 | Tobramycin inhalation solution | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1264 | Tobramycin Inhalation Solution (TIS) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1265 | Tobramycin inhalation solution using a PARI LC® Plus nebulizer. | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1266 | Tobramycin injection 40mg/1ml | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1267 | Tobramycin nebulized nasally | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1268 | Tobramycin Powder | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1269 | Tobramycin Solution for Inhalation | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1270 | Tobramycin solution for inhalation (TOBI) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1271 | Tobramycin solution for inhalation 300 mg | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1272 | Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1273 | TOBRAMYCIN SULFATE | 2件: Sulfate ion Sulfate ion, Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1274 | Tobramycine | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1275 | Tobramycinum | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1276 | Tobrineb/Bramitob | - | - | - | - | 1件: 299 299 |
1277 | Tocotrienol | 1件: Tocotrienol Tocotrienol | - | - | - | 3件: 21 21, 156, 299 |
1278 | TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML | - | - | - | - | 1件: 299 299 |
1279 | Tozinameran | 1件: Tozinameran Tozinameran | 1件: D11971
D11971
| - | - | 1件: 299 299 |
1280 | TR02 | - | - | - | - | 1件: 299 299 |
1281 | Tranexamic acid | 1件: Tranexamic acid Tranexamic acid | 1件: D01136
D01136
| 1件: PLG PLG 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 7件: 46 46, 70, 215, 227, 274, 288, 299 |
1282 | Transdermal estrogen | - | - | - | - | 1件: 299 299 |
1283 | Treatment | - | - | - | - | 2件: 41 41, 299 |
1284 | Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor | 4件: Elexacaftor Elexacaftor, Ivacaftor, Lumacaftor, Tezacaftor | 4件: D09916
D09916
,
D10134
,
D11041
,
D11507
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1285 | Treatment with polyethylene glycol (Macrogol 4000) | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 1件: 299 299 |
1286 | Trifakta | - | - | - | - | 1件: 299 299 |
1287 | Trikafta | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1288 | Trimethoprim | 1件: Trimethoprim Trimethoprim | 1件: D00145
D00145
| - | - | 7件: 36 36, 44, 49, 60, 61, 85, 299 |
1289 | Trimethoprim and Sulfamethoxazole | 2件: Sulfamethoxazole Sulfamethoxazole, Trimethoprim | 2件: D00145
D00145
,
D00447
| - | - | 1件: 299 299 |
1290 | Trimethoprim Sulfamethoxazole (TMP/SMX) | 3件: Sulfamethoxazole Sulfamethoxazole, TMP, Trimethoprim | 2件: D00145
D00145
,
D00447
| - | - | 1件: 299 299 |
1291 | Trimethoprim-Sulfamethoxazole | 2件: Sulfamethoxazole Sulfamethoxazole, Trimethoprim | 2件: D00145
D00145
,
D00447
| - | - | 3件: 49 49, 61, 299 |
1292 | Trimethoprim/Sulfamethoxazole | 2件: Sulfamethoxazole Sulfamethoxazole, Trimethoprim | 2件: D00145
D00145
,
D00447
| - | - | 1件: 299 299 |
1293 | Trimethoprim/Sulfamethoxazole (TMP/SMX) | 3件: Sulfamethoxazole Sulfamethoxazole, TMP, Trimethoprim | 2件: D00145
D00145
,
D00447
| - | - | 1件: 299 299 |
1294 | Trimetoprim | - | - | - | - | 1件: 299 299 |
1295 | Triple combination therapy | - | - | - | - | 1件: 299 299 |
1296 | Turmeric | 1件: Turmeric Turmeric | - | - | - | 4件: 140 140, 144, 158, 299 |
1297 | Ultrase | - | - | - | - | 1件: 299 299 |
1298 | Ultrase® MT12 | - | - | - | - | 1件: 299 299 |
1299 | Ultrase® MT20 | - | - | - | - | 1件: 299 299 |
1300 | ULTRESA | - | - | - | - | 1件: 299 299 |
1301 | Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein) | 1件: Genistein Genistein | 1件: D11680
D11680
| - | - | 1件: 299 299 |
1302 | Uridine | 1件: Uridine Uridine | - | - | - | 1件: 299 299 |
1303 | Urinary levels of PIIINP as a marker of changes in renal function | - | - | - | - | 1件: 299 299 |
1304 | Ursodiol | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 6件: 8 8, 20, 93, 97, 234, 299 |
1305 | V-Fend | - | - | - | - | 1件: 299 299 |
1306 | Vaccin grippal pandémique H1N1 | - | - | - | - | 1件: 299 299 |
1307 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件: 299 299 |
1308 | Valganciclovir | 1件: Valganciclovir Valganciclovir | 1件: D02495
D02495
| - | - | 4件: 85 85, 97, 299, 331 |
1309 | Valganciclovir [Valcyte] | 1件: Valganciclovir Valganciclovir | 1件: D02495
D02495
| - | - | 1件: 299 299 |
1310 | Vancomycin | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 |
1311 | Vancomycin hydrochloride inhalation powder | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 1件: 299 299 |
1312 | Vancomycin inhalation powder | 1件: Vancomycin Vancomycin | 1件: D00212
D00212
| - | - | 1件: 299 299 |
1313 | Vantobra (tobramycin) | 1件: Tobramycin Tobramycin | 1件: D00063
D00063
| - | - | 1件: 299 299 |
1314 | Vardenafil | 1件: Vardenafil Vardenafil | 1件: D08668
D08668
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 86, 299 |
1315 | Vaxzevria | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 299 299 |
1316 | Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 1件: 299 299 |
1317 | VEDROP | 1件: Tocofersolan Tocofersolan | 1件: D06174
D06174
| - | - | 1件: 299 299 |
1318 | Ventolin | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1319 | Ventolin® Evohaler | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1320 | Ventolin¿ Evohaler¿ | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
1321 | Vfend | 1件: Voriconazole Voriconazole | 1件: D00578
D00578
| - | - | 1件: 299 299 |
1322 | VFEND 40 mg/ml powder for oral suspension | 1件: Voriconazole Voriconazole | 1件: D00578
D00578
| - | - | 1件: 299 299 |
1323 | Vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 4件: 6 6, 201, 229, 299 |
1324 | Vitamin D | 1件: Vitamin D Vitamin D | - | - | - | 20件: 13 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 |
1325 | Vitamin D Oil | 1件: Vitamin D Vitamin D | - | - | - | 1件: 299 299 |
1326 | Vitamin D Powder | 1件: Vitamin D Vitamin D | - | - | - | 1件: 299 299 |
1327 | Vitamin D2 | 1件: Ergocalciferol Ergocalciferol | 1件: D00187
D00187
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 3件: 49 49, 84, 299 |
1328 | Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 12件: 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 |
1329 | Vitamin E | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 11件: 2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 |
1330 | VITAMIN E - TGPS | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 1件: 299 299 |
1331 | Vitamin K | 1件: Phylloquinone Phylloquinone | - | - | - | 2件: 46 46, 299 |
1332 | Vitamin K supplementation, dose #1 | 1件: Phylloquinone Phylloquinone | - | - | - | 1件: 299 299 |
1333 | Vitamin K supplementation, dose #2 | 1件: Phylloquinone Phylloquinone | - | - | - | 1件: 299 299 |
1334 | Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1 | 1件: Choline Choline | 1件: D07690
D07690
| - | - | 1件: 299 299 |
1335 | Voriconazole | 1件: Voriconazole Voriconazole | 1件: D00578
D00578
| - | - | 2件: 60 60, 299 |
1336 | VR496 | - | - | - | - | 1件: 299 299 |
1337 | VRT-813077 | - | - | - | - | 1件: 299 299 |
1338 | VRT-826809 | - | - | - | - | 1件: 299 299 |
1339 | VRT-893661 | - | - | - | - | 1件: 299 299 |
1340 | VRT-893661 VRT-0893661 | - | - | - | - | 1件: 299 299 |
1341 | VX-121 | - | - | - | - | 1件: 299 299 |
1342 | VX-121/TEZ/D-IVA | - | - | - | - | 1件: 299 299 |
1343 | VX-121/tezacaftor/deutivacaftor | 2件: Deutivacaftor Deutivacaftor, Tezacaftor | 2件: D11041
D11041
,
D11423
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1344 | VX-152 | - | - | - | - | 1件: 299 299 |
1345 | VX-371 | - | - | - | - | 1件: 299 299 |
1346 | VX-371 in hypertonic saline | - | - | - | - | 1件: 299 299 |
1347 | VX-371 in saline | - | - | - | - | 1件: 299 299 |
1348 | VX-440 | - | - | - | - | 1件: 299 299 |
1349 | VX-445 | - | - | - | - | 1件: 299 299 |
1350 | VX-445 / TEZ / IVA | - | - | - | - | 1件: 299 299 |
1351 | VX-445 / TEZ / IVA FDC | - | - | - | - | 1件: 299 299 |
1352 | VX-445 /TEZ/IVA | - | - | - | - | 1件: 299 299 |
1353 | VX-445/TEZ/IVA | - | - | - | - | 1件: 299 299 |
1354 | VX-522 mRNA therapy | - | - | - | - | 1件: 299 299 |
1355 | VX-561 | - | - | - | - | 1件: 299 299 |
1356 | VX-561 (CTP-656) | - | - | - | - | 1件: 299 299 |
1357 | VX-659 | 1件: VX-659 VX-659 | - | - | - | 1件: 299 299 |
1358 | VX-659/ TEZ/IVA | 1件: VX-659 VX-659 | - | - | - | 1件: 299 299 |
1359 | VX-659/TEZ/IVA | 1件: VX-659 VX-659 | - | - | - | 1件: 299 299 |
1360 | VX-659/Tezacaftor/Ivacaftor | 3件: Ivacaftor Ivacaftor, Tezacaftor, VX-659 | 2件: D09916
D09916
,
D11041
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1361 | VX-661 | - | - | - | - | 1件: 299 299 |
1362 | VX-661 / VX-770 | - | - | - | - | 1件: 299 299 |
1363 | VX-661 Plus Ivacaftor Combination | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1364 | VX-661, VRT-893661 | - | - | - | - | 1件: 299 299 |
1365 | VX-661/Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1366 | VX-661/ivacaftor (VX-770) 100mg/150 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1367 | VX-661/ivacaftor 100 mg/ 150 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1368 | VX-661/ivacaftor 100mg/150 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1369 | VX-661/ivacaftor 100mg/150mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1370 | VX-661/ivacaftor 50 mg/ 75 mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
1371 | VX-661/VX-770 | - | - | - | - | 1件: 299 299 |
1372 | VX-661/VX-770 (TEZ/IVA) | - | - | - | - | 1件: 299 299 |
1373 | VX-77 | - | - | - | - | 1件: 299 299 |
1374 | VX-770 | - | - | - | - | 1件: 299 299 |
1375 | VX-770, VRT-8130077 | - | - | - | - | 1件: 299 299 |
1376 | VX-770, VRT-813077 | - | - | - | - | 1件: 299 299 |
1377 | VX-809 | - | - | - | - | 1件: 299 299 |
1378 | VX-809 & VX-770 | - | - | - | - | 1件: 299 299 |
1379 | VX-809 / VX-770 | - | - | - | - | 1件: 299 299 |
1380 | VX-809, VRT-826809 | - | - | - | - | 1件: 299 299 |
1381 | VX-809/VX-770 | - | - | - | - | 1件: 299 299 |
1382 | Water | 1件: Water Water | 1件: D00001
D00001
| - | - | 21件: 2 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 |
1383 | Water for injections | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 299 299 |
1384 | WATER FOR INJECTIONS, EP | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 299 299 |
1385 | WRAIR_PAM-CF1 | - | - | - | - | 1件: 299 299 |
1386 | Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 3件: 22 22, 85, 299 |
1387 | Xenon-129 | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
1388 | Xolair | 1件: Omalizumab Omalizumab | 1件: D05251
D05251
| 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 2件: 46 46, 299 |
1389 | Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung | 1件: Omalizumab Omalizumab | 1件: D05251
D05251
| 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 299 299 |
1390 | Xylitol | 1件: Xylitol Xylitol | 1件: D00061
D00061
| - | - | 2件: 53 53, 299 |
1391 | Zadaxin | - | - | - | - | 2件: 65 65, 299 |
1392 | ZAVESCA | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 19 19, 256, 299 |
1393 | Zenpep | - | - | - | - | 2件: 298 298, 299 |
1394 | Zinc | 1件: Zinc Zinc | - | - | - | 3件: 2 2, 171, 299 |
1395 | Zinc acetate | 2件: Acetate Acetate, Zinc acetate | 1件: D06408
D06408
| - | - | 2件: 171 171, 299 |
1396 | Zinc acetate (20mg/d) | 3件: Acetate Acetate, Zinc, Zinc acetate | 1件: D06408
D06408
| - | - | 1件: 299 299 |
1397 | ZITHOMAX 40 mg/ml ENFANTS | - | - | - | - | 1件: 299 299 |
1398 | Zithromax | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 2件: 228 228, 299 |
1399 | ZITHROMAX 250 mg | 1件: Azithromycin Azithromycin | 2件: D06390
D06390
,
D07486
| - | - | 1件: 299 299 |
1400 | Zitromax | - | - | - | - | 2件: 228 228, 299 |
1401 | Zn | - | - | - | - | 2件: 113 113, 299 |
1402 | Zoledronic acid | 1件: Zoledronic acid Zoledronic acid | 2件: D01968
D01968
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 12件: 5 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 |